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In the first part of the present study, myostatin-1 and myostatin-2 cDNAs have 
been isolated from silver sea bream (Sparus sarba). The full length myostatin-1 
eDNA comprises a 1140 bp open reading frame encoding 379 amino acids whereas 
the partial myostatin-2 eDNA has 363 bp which encodes for 121 amino acids. 
Myostatin-1 was expressed in many different organs in silver sea bream; whereas 
myostatin-2 was mainly expressed in muscle and brain. Expression levels of both 
myostatin-1 and myostatin-2 in tissues of sea bream in different seasons were also 
evaluated through real-time PCR. Myostatin was expressed at a higher level in 
summer compared to that in winter in silver sea bream. The different expression 
levels of myostatin through different seasons suggest that myostatin may have 
functions in growth which was affected by environmental factors. 
In the second part of the study, silver sea bream were injected with growth 
hormone (GH), 11- ketotestosterone (11KT) or cortisol. Myostatin expression levels 
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have been measured by using RT-Real-time PCR. Growth hormone resulted In a 
decreased myostatin-1 expression In white muscle and an increased myostatin 
expression in red muscle. 11 KT decreased the myostatin-1 mRNA amount in red 
muscle. Cortisol injection resulted in an increased myostatin-1 expression in red 
muscle which is opposite to the expected. These results suggest that myostatin is 
involved in the complex hormone regulation in growth progress. 
In the third part, myostatin-1 expression levels were examined in silver sea 
bream exposed to different salinities. Two sets of experiments were carried out: the 
first experiment involved the long term adaptation of fish to 33ppt, 12ppt and 6ppt 
respectively and the second experiment involved abrupt transfer of fish from 33ppt to 
6ppt. Expression levels of myostatin-1 in white muscle, red muscle, gill and kidney 
were recorded. The expression of myostatin-1 in all these tissues was unchanged over 
the salinity range tested in both the long term adaptation experiment and the abrupt 
transfer experiment for 72h. However, there were significant increases of myostatin-1 
expression in red muscle and gill and a decrease of myostatin-1 in kidney in silver sea 
bream 24h after abrupt transfer from 33ppt to 6ppt. These results showed that 
myostatin-1 may be involved in short term adaptation for salinity change. 
IV 
摘要
本研究第一部分完成了黃錫網( Sparus sarba ) 肌肉抑制素-1 的完整基因序
列和肌肉抑制素-2 的片段基因序列的克隆。肌肉抑制素-1 完整基因的開放閱讀
框總長 1140 個城基對，編碼 379 個氮基酸。肌肉抑制素-2 的克隆片段含有 363
















轉移至低滲鹽度(千分之六)環境中 24 小時及 72 小時，並與對照組轉移即將海
水中馴養之黃錫綱直接轉移至海水中進行比較。結果表明，在長期馴養試驗和直
接轉移 72 小時試驗中，肌肉抑制素-1 於臼肌、紅肌、肥和腎臟中的表達沒有因
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Silver sea bream (Sparus sarba) used in this study is a kind of excellent food fish 
with high commercial value. The species is characterized by having an extensive 
period of postlarval muscle growth (Rowlerson and Veggetti 2001 ). Compared to 
traditional fish models such as zebrafish which show little postlarval skeletal muscle 
growth and reach only small adult sizes, species like sea bream is a better model 
organism for studying muscle development and myostatin gene in teleost fish 
(Maccatrozzo et al., 2001 b). 
Myostatin (MSTN) is a member of the transforming growth factor-B (TGF-B) 
superfamily discovered about 10 years ago (McPherron et al., 1997). The TGF -~ 
superfamily encodes secreted factors that are important for regulating embryonic 
development and tissue homeostasis in adult, for example, the well known activin and 
bone morphogenetic proteins (BMPs) (Crampton and Luckhart, 2001). Myostatin 
regulates muscle growth negatively by inhibiting the proliferation and differentiation 
of myoblast through a TGF-~ signaling pathway (Rios et al., 2002; Thomas et al., 
2000), resulting in myostatin deficient animals such as myostatin knockout mice 
displaying double muscling phenotype (McPherron et al., 1997). In mammals, such as 
mice, the expression of myostatin is almost exclusively found in skeletal muscle 
among the different tissues (McPherron et al., 1997). In fish, a second myostatin 
isoform was also found in 2001 by Robert and Goetz in brook trout (Roberts and 
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Goetz, 2001) and .in some other fish species (Maccatrozzo et al., 2001 a; Ostbye et al., 
2001; Roberts and Goetz, 2001; Rodgers et al., 2001). Myostatin-1 mRNA was 
expressed in many different tissues such as gill and kidney, but myostatin-2 mRNA 
was mainly expressed in brain and muscle (Helterline et al., 2007; Res can et al., 2001 ). 
Several studies have shown that myostatin can be regulated by many hormones such 
as growth hormone, testosterone, 11-ketotestosterone and cortisol in both mammalian 
and teleostean species (Biga et al., 2004; Liu et al., 2003; Mendler et al., 2007; 
Roberts et al., 2004; Rodgers et al., 2003). However, no studies on myostatin have 
been conducted using silver sea bream and the results on other teleost species were far 
from conclusive. As such, elucidation of the hormonal regulation of myostatin 
expression is the main focus of the present study. 
In Chapter 2, the basic background information about myostatin and the 
literature on previous studies on myostatin in both mammalian and teleostean species 
will be reviewed in detail. 
Several studies have shown that the structure of myostatin shares many common 
characteristics with all members of the family: a hydrophobic core of amino acids at 
the N-terminal that functions as a secretory signal, a proteolytic processing site 
(RXXR), a cysteine knot containing nine cysteine residues which is essential for 
TGF-~ activity, and a bioactive C-terminal domain. Proteolytic processing of 
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myostatin results . in a N-terminal Latency Associated peptide (propeptide) and the 
C-terminal mature myostatin peptide (Thomas et al., 2000). Myostatins of many 
different species exhibit highly conserved C-terminal bioactive region, indicating that 
myostatin may have similar function throughout evolutionary diverse animals. In 
Chapter 3, the first part of this study, characteristics of both myostatin-1 and 
myostatiri-2 in silver sea bream will be examined. The mRNA expressions of these 
two myostatins in silver sea bream in different seasons were quantified. 
In Chapter 4, the effects of growth hormone, 11-ketotestoetrone and cortisol on 
myostatin mRNA expression in silver sea bream were studied. Myostatin can be 
regulated by many hormones. In a murine C2C12 cell line, growth hormone treatment 
resulted in inhibition of myostatin mRNA (Liu et al., 2003). In another study on 
rainbow trout, growth hormone injection resulted in differential regulation of 
myostatin-1 and myostatin-2 as growth hormone induced myostatin-1 but reduced 
myostatin-2 (Biga et al., 2004). Testosterone has been shown to inhibit myostatin 
expression in rat (Mendler et al., 2007). Glucocorticoids such as dexamethasone and 
cortisol also have effects on myostatin. However, results of different studies are in 
conflict. In rat, myostatin mRNA was increased significantly after a single injection of 
dexamethasone (Lang et al., 2001 ). However, some studies on fish species showed a 
opposite result: In tilapia larvae, myostatin mRNA was reduced following cortisol 
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treatment (Rodgers et al., 2003). 
In the present study, silver sea bream were treated with growth hormone (GH), 
11-ketotestosterone ( 11 KT) or cortisol. Expression levels of myostatin-1 in white 
muscle and myostatin-2 in both white and red muscle from hormone treated fish were 
compared to those in controls to evaluate the effect of hormones on myostatin 
expression in silver sea bream. 
Studies on fish myostatin showed that myostatin-1 was expressed in gill and 
kidney in many teleost species such as sea bream, zebrafish and salmon (Ostbye et al., 
2001; Radaelli et al., 2003). Gill and kidney are important organs responsible for 
osmoregulation in fish, suggesting that myostatin may be involved in the 
osmoregulatory processes. The euryhaline fish silver sea bream is an excellent model 
for studying osmoregulation by virtue of its wide tolerance of a wide range of 
salinities (0-70ppt) (Deane and Woo, 2004, 2006; Wong et al., 2006). Thus in Chapter 
5, the possible osmoregulatory role of myostatin in silver sea bream will be examined 
by observing myostatin-1 expression levels in gill and kidney in silver sea bream 
following exposure to different salinities. 
The overall objective of the present thesis is to complete some basic studies on 
myostatin gene expression; to investigate the effects of different hormones on muscle 
myostatin mRNA expression; and to evaluate the effects of different salinity changes 
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on myostatin-1 mRNA expression in the main organs of osmoregulation in order to 
deduce if there is any unreported function of myostatin on osmoregulation in silver 
sea bream. These investigations may possibly lead to a better understanding about the 





2.1 An introduction to myostatin 
2.1.1 A general introduction 
The myostatin gene belongs to the transforming growth factor-~ (TGF- ~) 
superfamily which encodes secreted factors that are important for regulating 
embryonic development and tissue homeostasis in adult, for example, the well known 
activin and bone morphogenetic proteins (BMPs ). Myostatin inhibits myoblasts 
proliferation and differentiation which results in inhibition of muscle growth (Rios et 
al., 2002; Thomas et al., 2000). Mice with a targeted disruption of the myostatin gene 
display a marked increase in muscle mass, up to three times normal size, as a result of 
a combination of muscle fiber hyperplasia and hypertrophy (McPherron et al., 1997). 
Hyperplasia means the proliferation of cells, and hypertrophy which is different from 
hyperplasia is the increase of size of cell. The obvious increase in muscle mass is also 
observed in cattle Belgian Blue which has a natural mutation on the myostatin gene 
(McPherron and Lee, 1997). Myostatin is expressed initially in the myotomal 
compartment of developing somites and continues to be expressed in muscle 
throughout development and in adult animals (McPherron et al., 1997). In mammals, 
such as mice, there was only one type of myostatin and its expression is almost 
exclusively confined to the skeletal muscle among the different tissues (McPherron et 
al., 1997). However, in fish, a second myostatin isoform was also found in 2001 by 
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Robert and Goetz in brook trout (Roberts and Goetz, 2001) and in some other fish 
species (Maccatrozzo et al., 2001a; Ostbye et al., 2001; Roberts and Goetz, 2001; 
Rodgers et al., 2001). They found that the fragment obtained by PCR from ovary was 
different from that in muscle and brain. The ovary myostatin (ov MSTN or MSTN1) 
was expressed in many different tissues in include eye, gill, kidney, intestine, ovary 
and brain (Ostbye et al., 2001), and the brain and muscle myostatin (b/m MSTN or 
MSTN2) was mainly expressed in brain and muscle (Helterline et al., 2007; Rescan et 
al., 2001 ). 
2.1.2 Myostatin identification 
Myostatin was originally identified in a screen for novel mammalian members of 
the transforming growth factor-B (TGF-B) superfamily of growth and differentiation 
factors (McPherron et al., 1997). These authors carried out PCR on mouse genomic 
DNA by using degenerate primers which have been designed according to the 
conserved regions of known TGF-beta family members. 
A second myostatin was first found in 2001 by Robert and Goetz in brook trout 
(Roberts and Goetz, 2001). They found that the fragment obtained by PCR from the 
ovary was different from that in muscle and brain. The ovary myostatin (ov MSTN or 
MSTNl) was expressed in many different tissues, but the brain and muscle myostatin 
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(b/m MSTN or MSTN2) was mainly expressed in brain and muscle. Subsequently, it 
is known that there are two myostatin isoforms in many fish species, such as gilthead 
sea bream, Atlantic salmon and white bass (Maccatrozzo et al., 2001a; Ostbye et al., 
2001; Roberts and Goetz, 2001; Rodgers et al., 2001 ). 
2.1.3 Structural studies of myostatin 
As a member of the TGF-beta family, the structure of myostatin shares many 
common characteristics with all members of the family: a hydrophobic core of amino 
acids at the N-terminal that functions as a secretory signal, a proteolytic processing 
site (RXXR), a cysteine knot contains nine cysteine residues which are essential for 
TGF -~ activity and a bioactive C-terminal domain (Derynck and Miyazono, 2008). 
Proteolytic processing of myostatin results in a N-terminallatency associated peptide 
(propeptide) and the C-terminal mature myostatin peptide (Thomas et al., 2000). 
Myostatin of many different species possess a highly conserved C-terminal bioactive 
region, indicating that myostatin may have a similar function throughout evolution. 
2.1.4 Phenotype of myostatin-null animals or transgenic animals 
A. Mammals 
Myostatin expression in mammals is limited primarily to skeletal muscle, which 
10 
In mammals appears to be the principal target tissue. The muscle mass of 
myostatin-null cattle, dog, mice, and humans is much higher than normal animals and 
produces "double muscling" phenotype. Enhanced muscle growth in these animals 
may be due to increases in both hyperplastic growth and hypertrophic growth 
(McPherron et al., 1997). Studies on myostatin null mice showed that total muscle cell 
number was 86% higher in mutant animals compared to wild-type mice. Total DNA 
of the muscle mass of myostatin null mice is also increased. These results indicate a 
hyperplastic growth of muscle when the myostatin gene is silenced. Hypertrophic 
growth is manifest as increased fiber diameter (McPherron et al., 1997). In another 
study using myostatin overexpressed mice, results showed that myostatin can induce 
muscle atrophy (Reisz-Porszasz et al., 2003). Myostatin null phenotype has also been 
found in some mutant cattle breeds such as Piedmontese, Belgian Blue, and 
Marchigiana (Grobet et al., 1997; Kambadur et al., 1997; McPherron and Lee, 1997). 
B. Fish 
In fish species, myostatin is expressed in many different tissues, suggesting that 
myostatin may have function not only in skeletal muscle. Results from different 
studies on even the same fish species were very different so that there may be many 
different complex functions of myostatin in fish. Dramatic increase in body weight of 
zebrafish was obtained with the use of RNAi methods. The body weight of zebrafish 
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microinjected with 5.5x106 molecules of dsRNA for 75days was increased by 45% 
when compared with the control (Acosta et al., 2005). A double-muscled effect in 
transgenic zebrafish was also observed in another study using RNAi method as well 
(Lee et al., 2009). In that study, a hereditarily stable myostatin gene knockdown 
zebrafish strain with the double-muscle phenotype was established by microinjection 
of an antisense RNA-expressing vector. The resulting homozygous transgenic 
zebrafish were 45% heavier than control fish. The myogenic genes like myogenin and 
MyoD were also evaluated in transgenic fish and both exhibited dramatic 
upregulation (Lee et al., 2009). However, these results were very different from that 
of another study in which a transgenic zebrafish line overexpressing the myostatin 
prodomain in skeletal muscles was generated. The transgenic zebrafish have no 
significant change in muscle fiber size, and only exhibit 10% more myofibers than the 
non-transgenic fish. In addition, there are also no significant difference in myogenic 
gene expression and differentiation of muscle cells (Xu et al., 2003). Elucidation of 
the reasons for such discrepant results in different studies will await further studies. 
2.2 Regulation of myostatin 
2.2.1 Biosynthesis of myostatin 
Myostatin is synthesized primarily in n1uscle cell and then circulates into the 
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blood stream. Myostatin is synthesized as a precursor protein first, which is similar to 
other members of the TGF-beta family. The bioactive form of myostatin is generated 
by two proteolytic processing events on the precursor protein. The first processing 
event cuts a 24-amino acid signal peptide which is necessary for targeting the protein 
to the secretory pathway (McFarlane et al., 2005). The second cleavage occurs at the 
RXXR site and generates a N-terminal propeptide and a bioactive C-terminal part 
which possesses receptor binding activity (McFarlane et al., 2005). The second 
cleavage may be carried out by paired dibasic amino acid-cleaving enzyme (PACE or 
furin). Furin is a member of subtilisin-like serine proteinases family. In Lee and 
McPherron's study in 2001, they used a soluble form of furin to cut myostatin 
precursor protein at the proteolytic site RXXR in CHO cell (Lee and McPherron, 
2001 ). The pro peptide plays an important role in the proper folding of the C-terminal 
domain into a cysteine knot as in other TGF- beta family members. Two C-terminal 
fragments which folded into a cysteine knot forms a disulfide-linked dimer 
(McFarlane et al., 2005). 
2.2.2 Regulation of myostatin expression 
Myostatin can be regulated and affected by many factors, for example, hormones, 
transcriptional factors and other proteins. The highly conserved regulatory region of 
13 
the myostatin gene has several hormone-response site such as growth hormone 
response element, glucocorticoid response element, thyroid hormone response 
element and androgen response element (Duet al., 2005; Ma et al., 2001; Ma et al., 
2003; Roberts and Goetz, 2003). Transcription factor-binding motifs was also present 
such as MyoD binding site (Salerno et al., 2004; Spiller et al., 2002). Some studies 
showed that the myostatin gene is a downstream target gene of basic 
Helix-Loop-Helix transcription factor MyoD. There is a significant reduction in the 
myostatin promoter activity in cells that lack MyoD expression (Spiller et al., 2002). 
These response elements for different factors indicated that myostatin can be 
regulated at the transcription level. 
Myostatin is known to be regulated by vanous hormones. For example, 
testosterone has been shown to inhibit myostatin expression (Mendler et al., 2007). 
And as described, a glucocorticoid response element was identified on the myostatin 
promoter region. However, results ·from different studies are in conflict. In rat, 
' 
myostatin mRNA was increased 2.7-fold after a single injection of the synthetic 
glucocorticoid, dexamethasone. Pretreatment with the glucocorticoid receptor 
antagonist RU486 completely prevented the dexamethasone-induced increase in 
myostatin, confirming the effect of the glucocorticoid (Lang et al., 2001 ). However, 
some studies on fish species showed an opposite result: In tilapia larvae, myostatin 
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mRNA was reduced by 66 and 75% under cortisol treatment at 3h and 6h respectively 
(Rodgers et al., 2003 ). Results similar to those in tilapia were found in channel catfish 
in which a decrease in myostatin expression was recorded at 12 hours post 
dexamethasone (Dex) injection (Weber et al., 2005). Furthermore, fasting and stress 
which can lead to an increase in cortisol also resulted in decreased myostatin 
expression in fish (Rodgers et al., 2003; Vianello et al., 2003). Growth hormone 
response element was also identified upstream from the transcription start site in the 
myostatin gene of trout and mammal (Roberts and Goetz, 2001; Taylor et al., 2001 ). 
In mouse C2C 12 cell line, treatment of growth hormone resulted in inhibition of 
myostatin mRNA (Liu et al., 2003). Recently, there was a report of differential 
myostatin expression following growth hormone injection between two 
closely-related fish species, giant danio and zebrafish. In this study, myostatin was 
down-regulated in growth hormone-treated giant danio but up-regulated in zebrafish 
administered with growth hormone (Biga and Meyer, 2009). In a study using 
transgenic salmon overexpressing growth hormone as model, growth hormone had no 
effect on myostatin-1, but resulted in a decrease in white muscle myostatin-2 
expression and an increase in red muscle myostatin-2 expression. At the protein level, 
myostatin protein was decreased in both red and white muscle (Roberts et al. , 2004). 
Growth hormone injection in rainbow trout resulted in differential regulation of 
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myostatin-1 and myostatin-2: growth hormone induced myostatin-1 but reduced 
myostatin-2 (Biga et al., 2004). 
2.2.3 Regulation of myostatin protein 
In addition to regulation at the transcription level, myostatin also can be 
regulated at the protein level. Myostatin is found in serum and muscle tissue in 
several forms, bound to different protein partners. These proteins bind to myostatin 
protein, modulate its activation, secretion or receptor binding (Table 2.1 ). 
Follistatin 
Follistatin is an autocrine glycoprotein and can inhibit the activity of several 
members of the TGF beta family including the mature myostatin. Myostatin can bind 
to follistatin in skeletal muscle as mature myostatin form. As a consequence, this 
binding to follistatin inhibits binding of myostatin to its receptor (Lee and McPherron, 
2001 ). Muscle mass of transgenic mice overexpressing follistatin obtained by 
pronuclear injection of follistatin construct was increased by 194-327% relative to 
control animals, the larger muscle mass resulted from a combination of hyperplasia 
(66% increase in fiber number) and hypertrophy (28% increase in fiber diameter) (Lee 
and McPherron, 2001). 
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FLRG 
FLRG (follistatin-related gene) can directly bind to mature myostatin with high 
affinity and inhibit myostatin activity in a concentration-dependent manner as 
assessed by reporter gene assays. (Hill et al., 2002) 
GASP-I 
GASP-I (Growth and differentiation factor-associated serum protein-I) was 
discovered as a protein associated with endogenous myostatin in mice and human 
serum. GASP-I can directly bind to both mature myostatin and propeptide. Structural 
study showed that GASP-I contains multiple protease-inhibitory domains. So 
GASP-I is likely to inhibit the activity of proteases and as a consequence inhibit 
myostatin activity (Hill et al., 2003). 
Pro peptide 
Pro peptide 1s also very important in myostatin regulation. Using purified 
recombinant myostatin and propeptide protein as standards 1n Western blots to 
estimate the amount of these proteins purified from serum, Hill found that the 
majority (>70%) of circulating myostatin is bound to propeptide (Hill et al. , 2002). 
Experiment carried out in CHO cells also showed that the bioactive C-terminal dimer 
forms a noncovalent complex with the propeptide. The propeptide can maintain the C 
terminal bioactive myostatin in an inactive, latent state (McFarlane et al., 2005). The 
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ability of the propeptide to block the activity of the purified myostatin C-terminal has 
been documented in vitro and in vivo (Lee and McPherron, 2001; Thies et al., 2001 ). 
In Lee and McPherron 's study (Lee and McPherron, 2001 ), purified pro peptide can 
block the activity of the purified myostatin C-terminal dimer in vitro in Act RIIB 
receptor binding assay. In in vivo test, transgenic mice overexpressing myostatin 
propeptide obtained by pronuclear injection of propeptide construct showed increases 
in both muscle fiber number and size (Lee and McPherron, 2001 ). Consequently, one 
regulatory mechanism to activate myostatin C-terminal dimer is proteolytic cleavage 
of the propeptide. Injection of a mutant form of the propeptide (aspartate 76 was 
mutated to alanine) made resistant to proteolysis by the BMP-1/tolloid proteinases in 
vitro into mice for four weeks resulted in increases in muscle growth of 25% 
(Wolfman et al., 2003). 
hSGT 
Human small glutamine-rich tetratricopeptide repeat-containing protein (hSGT) 
can bind to the myostatin N-terminal signal peptide region and inhibits its secretion 
and activation (Wang et al., 2003). 
Decorin 
A proteoglycan found in the extracellular matrix, decorin, plays an important role 
in cell growth through the modulation of growth factor activities (Patel et al. , 1998; 
Yamaguchi et al., 1990). It also binds to TGF -~ via its core protein and modulates its 
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activity. Some studies showed that decorin interacts with myostatin and suppresses 
myostatin-mediated inhibitory action to muscle cell growth by keeping myostatin 
away from its receptor on muscle cells (Kishioka et al., 2004; Kishioka et al., 2008). 
T-cap 
Titin-cap (T -cap) is a sarcomeric protein that binds to the N-terminal domain of 
Titin and is a substrate of the titin kinase (Nicholas et al., 2002). Several assays 
including mammalian two-hybrid studies, in vitro binding assays and yeast 
two-hybrid system suggested the specific interaction between processed mature 
myostatin and full-length T -cap (Nicholas et al., 2002). The rate of cell proliferation 
was significantly increased in T -cap overexpressing C2C 12 myoblasts. Western 
analyses showed that production and processing of myostatin were not affected in 
T -cap overexpressing myoblast, however, an increase in mature myostatin indicated 
that T -cap may block myostatin secretion. These results suggest that T -cap may 
control myostatin secretion in myoblast but does not affect the proteolytic processing 
step of precursor myostatin (Nicholas et al., 2002). 
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Table 2.1 
Myostatin binding proteins 
Binding molecule Binding form Consequence of binding 
Myostatin propeptide Mature myostatin Inhibits myostatin receptor 
binding 
GASP I Mature myostatin & Inhibits myostatin activation 
propeptide 
FLRG Mature myostatin Inhibits myostatin activation 
hSGT Myostatin N-terminal Inhibits myostatin secretion and 
signal peptide region activation 
Titin cap Mature myostatin Inhibits myostatin secretion 
F ollistatin Mature myostatin Inhibits myostatin receptor 
binding 
2.3 Myostatin effect 
2.3 .1 The myostatin signaling pathway 
As a member of the TGF -beta family, the signaling pathway of myostatin is 
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similar to most .other TGF -beta ligands, which signal through high affinity 
transmembrane receptors, the type I and type II serine/threonine kinase receptors. In 
the absence of ligand, type II and type I receptors homodimerize at the cell surface. 
After ligand binding to type II receptor occurs, the type I receptor was phosphorylated 
by the ligand-bound type II receptor. This leads to type I serine/threonine kinase 
receptor activation which in tum phosphorylates the Smad protein (Joulia-Ekaza and 
Cabello, 2006) (Fig 1 ). 
Three kinds of Smad proteins are involved in TGF -beta ligand family signaling 
pathway: receptor regulated Smad (R;...Smads), common mediator Smad (Co-Smads) 
and inhibitory Smad (I-Smads). R-Smads including Smad 1, 2, 3, 5 and 8 are Smad 
proteins activated by type I receptors through phosphorylation (Zhu et al., 2004 ). 
After phosphorylation or activation of R-Smads, Co-Smads bind to the activated 
R-Smads and the complex can accumulate in the cell nucleus where they regulate 
transcription of specific target genes. I -Smads inhibit the TGF -beta pathway by two 
mechanisms. Firstly, I-Smads can compete with R-Smads for binding to activated 
receptors. Secondly (Hata et al., 1998), I-Smads compete with co-Smads for binding 
of activated R-Smads. Expression of 1-Smads can be stimulated by TGF-beta ligand. 
So 1-Smads can regulate the TGF-beta pathway through negative feedback (Imamura 
et al., 1997). 
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There are several kinds of type II receptors which respond to different ligands, 
such as ActRIIA (activin type II receptor), ActRIIB and BMPRII (bone 
morphogenetic protein type II receptor). In Lee and McPherron's cross-linking 
experiments in 2001, COS-7 cells transfected with express ton constructs for the 
indicated receptors were incubated with 125I-myostatin and crosslinking agent and 
analyzed by SDS/P AGE. Results showed that both ActRIIA and ActRIIB can bind to 
myostatin. The ActRIIB receptor exhibits a much higher level of binding than 
ActRIIA (Lee and McPherron, 2001 ). Injection of recombinant extracellular domain 
of goldfish ActRIIB also led to an increase in muscle mass and protein content in 
goldfish (Carpio et al., 2009). 
Studies have established that R-Smads Smad2 and Smad3 and co-Smad Smad4 
are involved in myostatin signaling. I-Smad Smad7 can inhibit myostatin signal. In 
addition, myostatin expression of Smad7 is induced by myostatin, leading to a 
negative regulatory feedback loop mechanism (Zhu et al., 2004). 
The myostatin signaling pathway is shown in Figure 2.1 which was excerpted 
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Fig. 2.1. Myostatin signaling pathway. Redrawn based on Figure 1 from The 
myostatin gene: physiology and pharmacology relevance (Joulia-Ekaza and Cabello, 
2007). 
2.3 .2 Cellular response for myostatin signaling 
It is known that myostatin inhibits skeletal muscle growth by inhibiting the 
proliferation and differentiation of myoblasts (Rios et al., 2002; Thomas et al. , 2000). 
The whole process is shown in Figure 2.2. 
The growth of myoblast is inhibited by incubation with myostatin-plus medium. 
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Treatment with myostatin also results in increased G 1 phase cell number and 
decreased S phase cell number, which indicates that myostatin can lead to cell 
withdrawal from the cell cycle and consequently leading to arrest In G 1 phase 
(Thomas et al., 2000). So the process of inhibiting cell proliferation by myostatin may 
occur through the regulation of myoblast cell cycle by interrupting the transition of 
G 1 phase to S phase. G 1-S phase transition required S phase specific transcription 
factor which is inhibited by Rb (retinoblastoma) protein binding. Cyclin-Cdk complex 
can phosphorylate Rb protein and the phosphorylated Rb can no longer bind to 
transcription factor and permitting transcription of S phase genes. Cyclin-Cdk 
inhibitors (CKis) can inhibit cyclin-Cdk and as a consequence inhibit the G 1-S phase 
transition(Becker et al., 2000). A CKI p21 seems to be promoted by myostatin. p21 
protein was induced and Cdk2 activity was decreased in myostatin-treated myoblast 
as measured by Western blot. Myostatin treatment also causes a decrease in the 
hyperphosphorylated form of Rb and a corresponding Increase In the 
hypophosphorylated form Rb protein. The increased hypophosphorylated form Rb 
may be caused by the inhibitory effect of myostatin-promoted p21 on Cyclin-Cdk 
(Thomas et al., 2000). 
Myotube formation was inhibited in C2C 12 cells overexpressing myostatin, 
indicating that myostatin can inhibit muscle cell differentiation. This inhibitory action 
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of myostatin may· be mediated by the down-regulation of the transcription factor 
required for myoblast differentiation, MyoD and myogenin (Rios et al., 2002). 
Expression of MyoD, myogenin and Mrf 4 were found to be increased in myostatin 
gene knockdown zebrafish (Lee et al., 2009). Some studies showed that myostatin can 
down-regulate MyoD expression by increasing Smad 3 • MyoD association. Myostatin 
signaling specifically induced Smad 3 phosphorylation and increased Smad 3-MyoD 
association, suggesting that Smad 3 may mediate the myostatin signal by interfering 
with MyoD activity and expression (Langley et al., 2002). 
· Precursors Myoblasts 
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Fig. 2.2. Myostatin inhibits myoblast proliferation and differentiation 
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2.4 Functions in tissues other than muscle 
Myostatin is also expressed minimally in some other tissues in mammals such as 
adipose tissue and heart (Rodgers and Garikipati, 2008). Myostatin can inhibit the 
differentiation of 3T3-Ll preadipose cells from human in vitro (Kim et al., 2000; Kim 
et al., 2001 ). In contrast, myostatin is shown to promote adipogenesis in vitro in 
Artaza's study (Artaza et al., 2006). Myostatin can inhibit the growth of 
cardiomyoblast and can also suppress cardiomyocyte hypertrophic growth responses 
(Morissette et al., 2006; Shyu et al., 2005). Myostatin may play similar function in 
heart with what it does in muscle (Rodgers and Garikipati, 2008). 
Many studies have shown that myostatin is expressed in different brain regions 
of different vertebrates (Radaelli et al., 2003; Rodgers and Garikipati, 2008), although 
its function in the brain is not clear. As a growth differentiation factor GDF -11 shares 
a very similar bioactive domain with myostatin, suggesting that myostatin may be 
similar to GDF -11 in playing a role in neurogenesis. GDF -11 regulates neurogenesis 
negatively, and its inhibitory effect on neurogenesis through inducing cell cycle arrest 
in . neuroprogenitors cells was proved in studies in olfactory epithelium (Wu et al. , 
2003 ). Both myostatin 1 and myostatin 2 were expressed in fish brain with high levels, 
suggesting that myostatin may play a similar function with GDF -11 in brain (Rodgers 
and Garikipati, 2008). 
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2.5 Myostatin in fishes 
2.5.1 Introduction to silver sea bream (Sparus sarba) 
The scientific name of Silver sea bream is Sparus sarba, its synonym name is 
Rhabdosargus sarba. This species belong to order Perciformes, family Sparidae. They 
have deep, ovate and compressed body. They have round head and obtuse snout. The 
caudal fin is forked. They are called silver sea bream or gold-line sea bream as their 
bodies are silver in color with yellow longitudinal stripes on both sides of the body. 
The maturity size is about 26 em TL and the maximum size is 80 em TL (WWF). 
Silver sea bream is a kind of euryhaline fish which are able to adapt a wide range of 
salinities. The fish is a kind of excellent food fish with high commercial value. FAO 
reported that world supply of sea bream has increased over time and silver sea bream 
represents a large percentage (about 30%) (FAO). Silver sea bream show extensive 
postlarval muscle growth and can reach large adult size (to at least 26 em TL). So it is 
a suitable model for studying muscle development of teleost fish. 
2.5.2 Studies carried on in fishes 
In fish species, there are two myostatin genes. The second myostatin was first 
found in 2001 by Robert and Goetz in brook trout (Roberts and Goetz, 2001 ). After 
that, the two myostatin genes were identified in many other teleosts such as gilthead 
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sea bream, Atlantic. salmon and white bass (Maccatrozzo et al., 2001 a; Ostbye et al., 
2001; Roberts and Goetz, 2001; Rodgers et al., 2001 ). The expression pattern of 
myostatin in fish species was very different from that in mammals. Myostatin-1 was 
shown to have a far more diverse expression pattern than that in mammal (Johansen 
and Overturf, 2005; Maccatrozzo et al., 2001 b; Ostbye et al., 2001; Roberts and Goetz, 
2001; Rodgers et al., 2003). The expression pattern suggests that myostatin may 
have function not only in skeletal muscle. Myostatin-2 was mainly expressed in 
muscle and brain (Maccatrozzo et al., 2001 a; Ostbye et al., 2001; Roberts and Goetz, 
2001; Rodgers et al., 2001 ). 
Fish meat is one of the most important foods in the world. The demand is very 
high and it is a healthy food because of its high content of Omega 3 fatty acid. Omega 
3 fatty acids are good for the heart and it has been suggested to reduce risk for 
cardiovascular diseases. So a study about fish muscle growth is important and useful 
to the production of food fish. Manipulating myostatin gene expression seems to be a 
possible way to increase the fish muscle mass as myostatin is suggested to be a 
negative regulator for muscle growth in mammals (McPherron et al., 1997). People 
try to study the function of myostatin in fish by overexpressing or silencing the gene. 
Dramatic increase in body weight of zebrafish was obtained by RNAi methods. The 
body weight of zebrafish microinjected with 5.5x 106 molecules of dsRNA for 75days 
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was increased by .45% when compared with the control (Acosta et al., 2005). 
However, the results were very different from that of another study in which a 
transgenic zebrafish line overexpressing the myostatin prodomain in skeletal muscles 
was generated. The transgenic zebrafish have no significant change in muscle fiber 
size, and only exhibit 10% more myofibers than the non-transgenic fish (Xu et al., 
2003). 
The regulation of myostatin at the RNA or protein levels was also very important 
and was studied by many groups. In mammals, there are many factors which have 
been shown to regulate myostatin at the protein level (Table 2.1 ). In addition, several 
hormones response elements were found in the 5' regulatory region on the myostatin 
gene. Hormones response elements were also found in several fish species. 
Interactions of myostatin with some important growth related hormones have been 
studied, for example, growth hormone and cortisol. In a study using transgenic 
salmon overexpressing growth hormone as model, growth hormone had no effect on 
myostatin-1, but resulted in a decrease in white muscle myostatin-2 expression and an 
increase in red muscle myostatin-2 expression. At the protein level, myostatin protein 
was decreased in both red and white muscle (Roberts et al., 2004). Growth hormone 
injection in rainbow trout results in differential regulation of myostatin-1 and 
myostatin-2: growth hormone induced myostatin-1 but reduced myostatin-2 (Biga et 
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al., 2004). In tilapia larvae, myostatin mRNA was reduced by 66 and 75% following 
cortisol treatment at 3h and 6h respectively (Rodgers et al., 2003). Although these 
results were opposite to the findings in mammals, they were consistent with those in 
channel catfish in which a decrease in myostatin expression was recorded at 12 hours 
post dexamethasone (Dex) injection (Weber et al., 2005). Results of studies on 
hormones effect on myostatin in fish were very different from those in mammals or 
even in different fish species. It indicates a possible different function of myostatin in 
teleosts and more studies are required to elucidate these possible novel functions. 
2.5.3 Possible novel functions of myostatin in fishes 
Myostatin was expressed in gill and kidney in many teleost species such as sea 
bream, zebrafish and salmon (Ostbye et al., 2001; Radaelli et al., 2003). Gill and 
kidney are important organs responsible for osmoregulation in fish. So myostatin may 
play roles in the osmoregulation processes. In gills, myostatin was localized in either 
the chloride or mucus cell at the primary lamellae in Ostbye's study (Ostbye et al., 
2001 ). Considering the function of myostatin in myoblast and the role of TGF -beta 
family members in the cell, myostatin may play a role in chloride cell differentiation 
in fish gills, but this aspect of chloride cell function has never been fully investigated. 
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Chapter 3 
Characterization of myostatin gene in the silver sea 
bream (Sparus sarba) 
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3.1 Abstract 
Myostatin-1 and myostatin-2 cDNAs have been isolated from silver sea bream 
(Sparus sarba). The full length myostatin-1 eDNA contains 1140 bp open reading 
frame encoding 379 amino acids whereas the partial myostatin-2 eDNA has 363 bp 
which encodes for 121 amino acids. The amino acid sequence of silver sea bream 
myostatin-1 is highly conserved with those of other fish and mammalian species 
especially for the bioactive C-terminal region. Phylogenetic analysis of myostatin in 
different animals suggests close evolutionary relationships. Myostatin is a member of 
TGF -beta family and the sequence· isolated 1n this study possesses all the 
characteristics of that family. Reverse transcriptase polymerase chain reaction 
(RT-PCR) on total RNA extracted from different sea bream tissues revealed 
myostatin-1 and myostatin-2 expression in skeletal muscle and non-muscle tissues 
such as brain, gill and kidney. The expression pattern of myostatin in fish differs from 
that in mammals, suggesting possible additional functions of myostatin in teleost 
species. Expression levels of both myostatin-1 and myostatin-2 in tissues of sea bream 
in different seasons were also evaluated through real-time PCR. Myostatin was 
expressed at a higher level in summer compared to that in winter in silver sea bream. 
The different expression levels of myostatin through different seasons suggest that 
myostatin may have functions in growth which are affected by environmental factors. 
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3.2 Introduction 
Myostatin (MSTN) is a member of the recently discovered family of proteins, 
the transforming growth factor-B (TGF-B) superfamily (McPherron et al., 1997). The 
TGF-~ superfamily encodes secreted factors that are important for regulating 
embryonic development and tissue homeostasis in adult, for example, the well known 
activin and bone morphogenetic proteins (BMPs) (Crampton and Luckhart, 2001 ). 
Myostatin regulates muscle growth negatively by inhibiting the proliferation and 
differentiation of myoblast through a TGF-~ signaling pathway (Rios et al., 2002; 
Thomas et al., 2000), resulting in myostatin deficient animals such as myostatin 
knockout mice displaying double muscling phenotype (McPherron et al., 1997). 
In mammals, such as mice, the expression of myostatin is almost exclusively 
found in skeletal muscle among the different tissues (McPherron et al., 1997). In fish, 
a second myostatin isoform was also found in 2001 by Robert and Goetz in brook 
trout (Roberts and Goetz, 200 1) and in some other fish species (Maccatrozzo et al., 
2001a; Ostbye et al., 2001; Roberts and Goetz, 2001; Rodgers et al., 2001). These 
authors found that the fragment obtained by PCR from ovary was different from that 
in muscle and brain. The ovary myostatin (ov MSTN or MSTN1) was expressed in 
many different tissues, and the brain and muscle myostatin (b/m MSTN or MSTN2) 
was mainly expressed in brain and muscle (Helterline et al., 2007; Rescan et al., 
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2001). 
As a member of the TGF-beta family, the structure of myostatin shares many 
common characteristics with all members of the family: a hydrophobic core of amino 
acids at the N-terminal that functions as a secretory signal, a proteolytic processing 
site (RXXR), a cysteine knot containing nine cysteine residues which is essential for 
TGF -~ activity, and a bioactive C-terminal domain. Proteolytic processing of 
myostatin results in a N-terminal Latency Associated peptide (propeptide) and the 
C-terminal mature myostatin peptide (Thomas et al., 2000). Myostatins of many 
different species exhibit highly conserved C-terminal bioactive region, indicating that 
myostatin may have similar function throughout evolutionary diverse animals. 
Silver sea bream (Sparus sarba) used in this study is a kind of excellent food fish 
with high commercial value. It has an extensive period of postlarval muscle growth 
(Rowlerson and V eggetti 2001 ). Compared to traditional fish models such as 
zebrafish which show little postlarval skeletal muscle growth and reach only small 
adult sizes, species like sea bream is a better model organism for studying muscle 
development in teleost fish (Maccatrozzo et al., 2001 b). 
34 
3.3 Materials and .methods 
3.3.1. Experimental fish 
Silver sea bream (Sparus sarba) were obtained from a local fish farm and kept in 
recirculating and aerated seawater [33 parts per thousand (ppt)] in the Simon FS Li 
Marine Science Laboratory, the Chinese University of Hong Kong. Fish were fed 
daily with a formulated diet (Woo and Kelly, 1995). Tissue samples collected from 
fish were stored in TRI Reagent® (Molecular Research Center, Inc., Cincinnati, OH) 
in -80°C until extracted for total RNA. The fish used for the analysis of seasonal 
expression pattern of myostatin were obtained in June 2008 and allowed to grow in 
tanks and sampled in August, October, February and April respectively. The weights 
of the fish sampled in August, October, February, and April were 52.01±2.25, 
69.63±1.20, 86.89±2.67 and 1 09.48±2.35 respectively. 
3.3.2 Total RNA extraction and eDNA cloning of myostatin-1 and myostatin-2 in 
silver sea bream 
Total RNA was extracted from muscle of silver sea bream by us1ng TRI 
Reagent® (Molecular Research Center, Inc.) according to the manufacturer's protocol. 
The concentration of total RNA was determined by measurement of absorbance at 260 
run (conversion factor: lOD = 40ng RNA/ml). The purity of RNA was checked by 
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ratio of absorbance. at 260nm over which at 280nm. RNA integrity (intensity of 18s 
and 28s ribosomal RNA on gel) was assessed by gel electrophoresis of total RNA. 
Before performing reverse transcription, the extracted total RNA which was 
re-suspended in DEPC water was treated with deoxyribonuclease I (amplification 
grade, Invitrogen, Carlsbad, CA) to eliminate possible genomic DNA contamination. 
The total RNA was then transcribed reversely. to first-strand eDNA by M-MLV 
Reverse Transcriptase (Prom ega, Madison, WI) according to the manufacturer's 
instruction using oligo( dT) 15 primer. 
Two gene specific primers ·(5'-TTCTCGACCAGTACGACGTG-3' and 
5'-TAATCCAGTCCCAGCCAAAG-3') were designed based on gilthead sea bream 
myostatin-1 eDNA sequence (GenBank Accession no.: AF258448) and the other two 
gene specific primers (5' -CCCAGGACGAGTTGACCTCA-3' and 
5'-CGGACTCTGATTCGGGT GTT-3') were designed based on gilthead sea bream 
myostatin-2 eDNA sequence (GenBank Accession no.: AY046314). These primers 
were used to isolate a partial region of silver sea bream myostatin-1 and myostatin-2 
eDNA within the coding region respectively. The reaction mixture for the polymerase 
chain reaction consisted of 0.8 ~1 first strand eDNA, 1 x PCR buffer, 2.5 mM MgC12, 
0.2 mM dNTP, 0.2 ~M of each gene-specific primer and 0.4 U units of Taq DNA 
polymerase (total volume 20~1). The PCR amplification was carried out for 35 cycles 
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after the initial denaturing step at 94 oc for 5min, and each cycle consisted of 30 sec 
denaturing at 94 °C, 60 sec at 60°C for annealing, and 30 sec at 72°C for extension. 
The 35 cycles were followed by 10 min at 75°C for final extension. The PCR products 
were ligated to pCR®-TOPO® vector by using TOPO TA cloning® Kit (Invitrogen, 
Carlsbad, CA). NucleoSpin® Plasmid DNA Purification Kit (Macherey-Nagel, 
Brockville, Ontario) was used to extract plasmids containing target DNA from 
bacteria cells. The plasmids were subsequently sequenced. 
The 5' and 3' ends of silver sea bream myostatin-1 eDNA were obtained by 
Rapid Amplification of eDNA Ends (RACE) (Invitrogen, Carlsbad, CA) according to 
the manufacturer's protocols. Based on the nucleotide sequence of the partial eDNA 
of silver sea bream, the antisense primer 5'-TCGAATCGAAGGCGTTAATC-3' was 
used 1n reverse transcription for 5 'RACE and antisense pnmer 
5'-TTCAGGGAGCGGATGTGTAT-3' and 5'-ACGACGGACTCAGGTTCAGT-3' 
and 5'-ACATCCCTGTTGTCGTCTCC-3' were used for PCR in 5'RACE together 
with Abridged Anchor Primer (AAP) and Abridged Universal Amplification Primer 
(AUAP). In 3' RACE, Adaptor Primer (AP) was used for first strand eDNA synthesis 
In reverse transcription. Two gene specific sense pnmers 
5 '-GTGGTTATGGAGGAGGACGA-3' and 5 '-AACCGTTCATGGAGGTGAAGA-
37 
3' were used for PCR together with AUAP. The PCR products of 5' and 3' RACE 
were subcloned as described above. 
3.3 .3 Multiple sequence alignment and unrooted trees 
The amino acid sequences of myostatin-1 and myostatin-2 of silver sea bream 
were aligned with those of other fish species using the multiple sequence alignment 
program T-Coffee (European Bioinformatics Institute, website: 
http://www.ebi.ac.uk/t-coffee). Unrooted trees were constructed using CLUSTALW 
(Kyoto University Bioinformatics Center, website: http://align.genome.jp). 
3.3.4 Detection ofmyostatin-1 and myostatin-2 mRNA in different tissues 
Based on the eDNA sequence of the previously cloned silver sea bream 
myostatin-1 and myostatin-2, gene specific pnmers were designed 
(5' -GGAGACGACAACAGGGATGT-3' and 5'-TTCAGGGAGCGGATGTGTAT-3' 
for MSTNl; 5'- CCCAGGACGAGTTGACCTCA-3' and 
5'-CGGACTCTGATTCGGGTGTT-3' for MSTN2). By us1ng these gene-specific 
primers, expression of myostatin-1 and myostatin-2 mRNA in different tissues (white 
muscle, red muscle, gill, kidney, intestine, heart, spleen, whole brain and several brain 
regions: olfactory bulb, telencephalon, hypothalamus, optic tectum, cerebellum, 
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medulla oblongata, spinal cord and pituitary) were examined by RT-PCR as 
previously described. The PCR products were checked ustng electrophoresis on 
agarose gel with ethidium bromide staining under UV illumination and documented 
using BIO-RAD gel doc. 
3.3.5. Real-time PCR for quantification ofmyostatin-1 and -2 mRNA expression 
Real-time quantitative RT-PCR was used to measure the mRNA expression of 
myostatin-1, myostatin-2 and a housekeeping gene 18s rRNA which acts as internal 
control for normalization. The standards for myostatin-1, myostatin-2 and 18s rRNA 
were prepared by RT-PCR amplification with the gene-specific primers 
(5' -GGAGACGACAACAGGGATGT-3' and 5'-TTCAGGGAGCGGATGTGTAT-3' 
for MSTN1; 5'- CCCAGGACGAGTTGACCTCA-3' and 
5' -CGGACTCTGATTCGGGTGTT-3' for MSTN2; 
5'-CTTGGATGTGGTAGCCGTTT-3' and 5'-GGATGCGTGCATTTATCAGA-3' for 
18s rRNA, designed according to the partial sequence of silver sea bream 18s rRNA 
(GenBank Accession no.: EF494673). Real time PCR was carried out using iCycler 
iQ TM Real-Time PCR Detection System (BioRad, Hercules, CA). The real-time PCR 
reactions were carried out in a total volume of 30J.!l containing 1 OJ.!l diluted RT 
reaction mix, l5J.!l iQ TM SYBR® Green Supermix (BioRad, Hercules, CA) and 0.2J..LM 
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of each primer pair as described above. The reaction consisted of an initial cycle of 
denaturation at 95°C for 4 minutes, 40 cycles of denaturing at 95°C for 30 seconds, 
annealing at 60°C for 30 seconds, extension at 72°C for 40 seconds and signal 
detection at 84 oc for 7 second. A melting curve analysis consisting of 17 6 cycles of 7 
seconds with temperature increase of 0.2°C I cycle was carried out at the end of the 
reaction to ensure the specificity of the reaction. 
3.3 .6 Data processing and statistical analysis 
The mRNA expression levels of rilyostatin-1 and myostatin-2 were normalized 
by 18s rRNA expression for each sample. Data were presented as mean ± SEM. 
Statistical analyses were performed using statistical program SIGMASTAT 2.0 and 
the differences were considered to be significant at p-value < 0.05 by one-way 
analysis of variance (ANOVA) and Newman-Keuls Multiple Comparison Test. 
3.4 Results 
3 .4.1 Cloning of myostatin-1 and myostatin-2 eDNA 
In the first round PCR, eDNA fragments of 584 bp and 363 bp were amplified 
using the gene-specific primers designed according to the sequence of gilthead sea 
bream myostatin-1 and myostatin-2 eDNA respectively. 
40 
The full length myostatin-1 sequence was obtained by RACE (Rapid 
Amplification of eDNA Ends). 5' and 3' RACE yielded products of 412 bp in the 5' 
region and 611 bp in the 3' region. Excluding the poly( A) tail, the full-length silver 
sea bream myostatin eDNA consists of 1631 nucleotides. This sequence is composed 
of a 129 bp 5' untranslated region, a 1140 bp open reading frame encoding 379 amino 
acid, and a 362 bp 3' untranslated region. As with all other members of TGF -beta 
family, silver sea bream myostatin gene possesses a proteolytic processing site RVRR 
(RXXR) and nine cysteine residues in the carboxy-terminal portion of the coding 
region. The proteolytic processing results in both a N-terminal propeptide (latency 
associated peptide, LAP) and a C-terminal mature myostatin peptide. Eight of the nine 
cysteine residues form disulfide bonds to create a cysteine knot and the ninth one 
forms a bond with the ninth cysteine of another myostatin molecule to form the dimer 
(Fig. 3.1 & Fig. 3.2). 
Alignment of the deduced amino acid sequence of silver sea bream myostatin-1 
and myostatin-2 with the amino acid sequences of human (GenBank Accession 
no. :NM 005259), mouse (NM 010834 ), and several teleost species including zebrafish 
(MSTN1: AY 258034; MSTN2: AY 687474), fugu (MSTN1: AY 445322; MSTN2: 
AY 445321), rainbow trout (MSTN1a: AF 273035; MSTN1b: AF 273036; MSTN2a: 
DQ 417326) and gilthead sea bream (MSTN1: AF258448; MSTN2: AY 046314) 
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produced by T-Coffee is shown in Fig 3.3. Results show that the bioactive C-terminal 
domains are highly conserved among various groups. Relationship among different 
animals was built up as unrooted trees calculated by CLUSTALW (Fig. 3.4). 
3 .4.2. Myostatin tissue distribution and seasonal pattern 
Silver sea bream myostatin-1 expression was detected mainly in white muscle, 
red muscle and brain. Low level of its expression was also detected in some other 
tissues such as gill and kidney (Fig 3.5). Myostatin-2 expression was only detected in 
red muscle, brain and a very low level in white muscle (Fig 3 .5). Figure 3.6 shows the 
result ~f MSTN expression level measured by real-time PCR in three different tissues: 
white muscle, red muscle and whole brain. Expressions of myostatin-1 in all these 
three tissues were higher than that of myostatin-2. Myostatin-1 expression was highest 
in red muscle which is 3.6 fold of white muscle. Myostatin-2 was mainly expressed in 
red muscle and whole brain which were respectively 107-fold and 15 5-fold higher 
than that in white muscle. 
Myostatin-1 expression in white muscle was highest in summer (August) (Fig. 
3. 7 A), while peak level of myostatin-1 expression in red muscle occurred in August 
and October (Fig. 3.7B). For both white and red muscle, myostatin-1 had lowest 
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expression in the spawning season (February). For myostatin-2 mRNA abundance, the 
highest expression was recorded in October and the lowest value was also found in 
February just like myostatin-1 (Fig. 3. 7C). 
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Figure 3.1 Full-length nucleotide sequence and deduced amino acid sequence of silver 
sea bream myostatin-1 eDNA, including the 1140 bp complete open reading frame 
(ORF) ~ncoding for 3 79 amtno acid with additional 412 bp 5' and 611 bp 3' 
untranslated regions (UTR). Asterisk indicates a stop codon. The nine cysteine residues 
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Figure 3.3 Multiple alignment of myostatin-1 and myostatin-2 amino acid sequence 
using T-Coffee. Deduced amino acid sequences of silver sea bream myostatin-1 and 
partial myostatin-2 were aligned with the amino acid sequences of myostatin of 
human, mouse, zebrafish, fugu, rainbow trout and gilthead sea bream using the 
multiple sequence alignment program T-Coffee. The legend below the alignment 
shows the different colors used to represent the degrees of amino acid homology 
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Figure 3.4 Unrooted neighbor-joining trees of myostatin--1 and myostatin--2 amino 
acid sequences 1n different vertebrates. Unrooted trees were constructed from the 
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Figure 3.5 Tissue distribution of myostatin-1 (MSTNl) and myostatin-2 (MSTN2) 
mRNA expression. OB : olfactory bulb ; Tel : telencephalon ; OT : optic tectum ; Ce : 
cerebellum; Mo : medulla oblongata; Sc : spinal cord; Pit: pituitary; Hypo: 
hypothalamus. I: intestine; G: gill; K: kidney; W: white muscle; B: whole brain; R: 
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Figure 3.6 Expression of myostatin-1 (MSTNI) and myostatin- 2 (MSTN2) in white 
muscle, red muscle and whole brain. WM: white muscle; RM: red muscle; Brain: 
whole brain. Data are presented as means ± SEM (n = 6-7 for each group). Significant 




























I- 0.005 (J) 
~ NO a 
0.000 

































































Apr Aug Oct 
Figure 3. 7 Seasonal variation of myostatin-1 expression in white muscle (A), red 
muscle (B) and myostatin-2 expression of red muscle (C) in silver sea bream. Data are 
presented as means± SEM (n =5-6 for each group). ND: not detectable. Significant 
difference (p < 0.05) between groups is illustrated in each figure by different letters. 
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3.5 Discussion 
In the present study, silver sea bream myostatin-1 (full length) and myostatin-2 
(partial) eDNA were isolated and sequenced. The amino acid sequences of 
myostatin-1 and myostatin-2 were deduced according to the eDNA sequence (Fig. 3.1 
& Fig. 3.2). For myostatin-1, the RT-PCR and RACE approaches generate 1631 
nucleotides and contained a 1140 bp open reading frame encoding 3 79 amino acid 
(Fig. 3.1). For myostatin-2, only a partial sequence of 121 amino acids was obtained 
because reactions involving RACE had failed. 
Myostatin is a member of the TGF -beta family. Similar to all other members in 
that family, the silver sea bream myostatin-1 possesses a RXXR (RVRR) proteolytic 
processing site, nine cysteine residues which correspond to TGF-beta activity and a 
bioactive C-terminal domain (McPherron et al., 1997) (Fig. 3.1 ). Silver sea bream 
myostatin-1 gene contains some microsatellite repeats. A (CAG) repeat was found in 
theN-terminal of the coding region to encode a polyglutamine stretch (6 residues). In 
3 '-UTR, there was a (AC) repeat. According to the result of multiple alignment of 
silver sea bream myostatin sequence with those of other animals, a noticeable site is 
the polyglutamine stretch in the myostatin of gilthead sea bream (12 residues) and 
silver sea bream ( 6 residues). There is no such site in the myostatins of higher 
vertebrates. It is possible that expansions of the polyglutamine tract would cause a 
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gene losing its function or gaining new functions, such as the case which has been 
reported for several human genetic disease genes such as the Huntington gene 
involved in Huntington's disease, in which expansion of the polyglutamine tract 
causes neutrophil aggregates (Kocabas et al., 2002; Paulson et al., 2000). 
Multiple alignment of sea bream myostatin with those of other teleost and 
mammalian species showed that silver sea bream myostatin amino acid sequence was 
highly conserved throughout evolution, especially in C-terminal bioactive region (Fig. 
3.3. ). The high level of evolutionary constraints suggests the importance of the 
function of this gene. 
In mammalian species, myostatin IS expressed mainly in skeletal muscle 
(McPherron et al., 1997), with expression in adipose tissue (McPherron et al., 1997), 
cardiac muscle (Sharma et al., 1999) and mammary gland (Ji et al., 1998) occurring at 
a lower level. In teleost species, there are two isoforms myostatin-1 and myostatin-2. 
The expression patterns of these two isoforms were different from· that of mammalian 
species, and were also different from each other. Myostatin-1 was expressed in a 
variety of tissues in many fish species such as gilthead sea bream (Maccatrozzo et al., 
2001 b), Atlantic salmon (Ostbye et al., 2001) and tilapia (Rodgers et al. , 2001 ). 
Different from myostatin-1, the expression of myostatin-2 was primarily expressed in 
brain (Maccatrozzo et al., 2001 a). In silver sea bream, myostatin-1 mRNA was 
56 
detected in white. muscle, red muscle, several regions of the brain, gill, kidney and 
very low expression level was detected in heart and intestine (Fig. 3.5); myostatin-2 
was expressed only in brain and red muscle and a very low level in white muscle, a 
finding which is consistent with results found in brook trout (Roberts and Goetz, 2001) 
and gilthead sea bream (Radaelli et al., 2003 ). 
Real-time quantitative RT-PCR showed that the expression level of silver sea 
bream myostatin-1 was higher than myostatin-2 in white muscle, red muscle and brain. 
myostatin-1 expression was highest in red muscle which was 3.6 fold of white muscle. 
myostatin-2 was mainly expressed · in red muscle and whole brain which were 
respectively 107-fold and 155-fold higher than that in white muscle (Fig. 3.6). Our 
results are consistent with the findings in gilthead sea bream and sole (Radaelli et al., 
2003). However, in rat and little tunny, myostatin expression is higher in white 
muscle (Matsakas et al., 2006; Roberts and Goetz, 2003). The high expression level of 
myostatin in red muscle and low expression level in white muscle suggest that 
myostatin may play a regulatory role in growth of different types of muscle fiber. In 
the sea bream, red muscle grows slowly compared to white muscle (Radaelli et al., 
2003). As a potent muscle negative regulator, myostatin may inhibit red muscle 
growth to adjust the growth rate of this muscle type. In fact, physiologically, white 
muscle and red muscle are very different in fish. White muscle or fast twitch muscle 
57 
is anaerobic and glycolytic and is mainly used for rapid burst activities. In general, 
white muscle fibers make up the bulk of fish, about 90%. The white muscle is white 
in color because of the presence of little amounts of myoglobin and thus the muscle is 
mainly anaerobic (Altringham and Ellerby, 1999). The oxidative slow twitch red 
muscle forms a relative small proportion of the total muscle mass and is usually 
located around the lateral line. Red muscle is used for slow steady swimming and its 
proportion is related to the ecology of the fish: constantly swimming pelagic species 
have more slow muscle than benthic species, and red muscle is entirely absent in 
some sluggish benthic species (Sanger and Stoiber, 2001; (Altringham and Ellerby, 
1999). 
The different patterns of myostatin- expression in fish and mammal suggest that 
the function of myostatin in fish may not be restricted to regulation of muscle growth. 
Many other studies also showed that myostatin is expressed in different brain regions 
(Radaelli et al., 2003; Rodgers and Garikipati, 2008). Some studies suggest that 
myostatin may have a similar function to a growth differentiation factor GDF -11 
which plays a role in neurogenesis as GDF -11 shares a very similar bioactive domain 
with myostatin. GDF-11 regulates neurogenesis negatively, and its inhibitory effect 
on neurogenesis through inducing cell cycle arrest in neuroprogenitors was proved in 
studies in olfactory epithelium (Wu et al., 2003). Both myostatin 1 and myostatin 2 
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were expressed in silver sea bream brain at high levels (Fig. 3.6) and therefore 
myostatin may play a similar function with GDF-11 in brain of fish species (Rodgers 
and Garikipati, 2008). Myostatin was expressed in gill and kidney in many teleost 
species such as gilthead sea bream, zebrafish, salmon (Ostbye et al., 2001; Radaelli et 
al., 2003) and silver sea bream (Fig. 3.5). Gill and kidney are important organs 
responsible for osmoregulation in fish, suggesting that myostatin may also participate 
in modulating fish osmoregulation process. In gills, myostatin was found in either 
chloride or mucus cell in Ostbye's study (Ostbye et al., 2001). Considering the 
function of myostatin in myoblasts artd the role of TGF -beta family members in the 
cell, it is possible that myostatin may play a role in chloride cell differentiation. 
In the present study, the expression level of myostatin in sea bream was shown to 
be different in different seasons. Real-time PCR measured that myostatin was 
expressed at a higher level in summer compared to that in winter in both white and 
red muscle in silver sea bream. For silver sea bream, winter (February) is the 
spawning season during which growth is generally suppressed (Tveiten et al. , 1998). 
Suppression of growth in the spawning season is expected to coincide with elevation 
of myostatin expression, and indeed some studies point towards this direction. For 
example in both brook trout and rainbow trout, although there was no change in 
myostatin mRNA expression (Johansen and Overturf, 2005; Roberts and Goetz, 2003), 
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muscle myostatin. protein level was significantly elevated during spawning in brook 
trout (Roberts and Goetz, 2003). However, other studies recorded a decrease of 
myostatin mRNA expression in the spawning season, for example, expression of 
myostatin-2 in both white and red muscle of rainbow trout was dramatically decreased 
at the time of spawning in both males and females (Rescan et al., 2001 ). Furthermore, 
some studies showed that MyoD2 expression was dramatically increased in spawning 
female rainbow trout and muscle hypertrophy occurred in spawning fish (Johansen 
and Overturf, 2005). Since myostatin can downregulate MyoD expression (Langley et 
al., 2002; Rios et al., 2002) and myostatin is a downstream target of MyoD (Spiller et 
al., 2002), a possible explanation of decreased myostatin expression is that although 
the growth rate decreased during spawning, myostatin and MyoD can keep muscle 
growth and avoid muscle atrophy. 
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Chapter 4 
Effects of growth hormone, 11-ketotestosterone 
and cortisol on myostatin mRNA expression in 
silver sea bream (Sparus sarba) 
61 
4.1 Abstract 
Myostatin (MSTN), which was first cloned in 1997, is an important negative 
regulator of skeletal muscle growth and belongs to the TGF-~ superfamily. Targeted 
disruption of myostatin gene in mice results in a marked increase in muscle mass, 
contributed by a combination of hypertrophy and hyperplasia. Growth 
hormone-responsive element and glucocorticoid-responsive element were recently 
identified upstream of the myostatin gene promoter region in some teleost species 
such as salmon. It indicates that growth hormone and cortisol may be possible 
regulators for myostatin. In order to study the relationship between these hormones 
and myostatin, in vivo and in vitro tests were carried out. Silver sea bream were 
injected with growth hormone (GH), 11- ketotestosterone (11KT) or cortisol. 
Myostatin expression levels have been measured by using RT-Real-time PCR. Growth 
hormone resulted in a decreased myostatin-1 expression in white muscle and an 
increased myostatin expression In red muscle. 11 KT decreased the myostatin-1 
mRNA amount in red muscle. Cortisol injection resulted in an increased myostatin-1 
expression in red muscle which is opposite to the expected. This anomalous result 
may be due to the stimulatory effect of cortisol on growth hormone secretion. 
Therefore an experiment was carried out to investigate the effect of cortisol on growth 
hormone secretion in silver sea bream pituitary cell culture which confirms the 
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stimulatory effect of cortisol. 
4.2 Introduction 
Myostatin (MSTN) is a member of transforming growth factor-B (TGF-B) 
superfamily discovered about 10 years ago (McPherron et al., 1997). Myostatin 
regulates muscle growth negatively by inhibiting the proliferation and differentiation 
of myoblast through a TGF- ~ signaling pathway (Rios et al., 2002; Thomas et al., 
2000). Myostatin knockout mice display double muscling phenotype (McPherron et 
al., 1997). In most fish species, there are two myostatin genes (Maccatrozzo et al., 
2001a; Ostbye et al., 2001; Roberts and Goetz, 2001; Rodgers et al., 2001) with 
different expression patterns. Myostatin-1 was expressed in many different tissues, 
but myostatin-2 was mainly expressed in brain and muscle (Helterline et al., 2007; 
Rescan et al., 2001 ). 
Myostatin can be regulated by many hormones. A growth hormone response 
element was also identified upstream from the transcription start site in the myostatin 
gene in trout and mammal (Roberts and Goetz, 2001; Taylor et al., 2001). In mouse 
C2C 12 cell line, treatment of growth hormone resulted in inhibition of myostatin 
mRNA (Liu et al., 2003). In a study using transgenic salmon overexpressing growth 
hormone as a model, growth hormone was shown to exert no effect on myostatin-1 
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expression, but resulted in a decrease in white muscle myostatin-2 expression and an 
increase in red muscle myostatin-2 expression. In the same study, myostatin protein 
was decreased in both red and white muscle (Roberts et al., 2004). In another study on 
rainbow trout, growth hormone injection resulted in differential regulation of 
myostatin-1 and myostatin-2 as growth hormone induced myostatin-1 but reduced 
myostatin-2 (Biga et al., 2004). 
11-ketotestosterone is a kind of fish specific testosterone which has profound 
anabolic effect (Gazola and Borella, 1997). Anabolic steroids such as testosterone has 
been shown to inhibit myostatin expression (Mendler et al., 2007). 
A glucocorticoid response element was also identified on the myostatin promoter 
region (Funkenstein et al., 2009; Ma et al., 2001 ). However, results of different 
studies are in conflict. In rat, myostatin mRNA was increased 2.7-fold after a single 
injection of dexamethasone. Pretreatment with RU486 completely prevented the 
dexamethasone-induced Increase 1n myostatin, confirming the effect of the 
glucocorticoid (Lang et al., 2001 ). However, some studies on fish species showed a 
opposite result: In tilapia larvae, myostatin mRNA was reduced by 66 and 75% under 
cortisol treatment at 3h and 6h respectively (Rodgers et al., 2003). 
In the present study, silver sea bream were treated with growth hormone (GH), 
11-ketotestosterone ( 11 KT) or cortisol. Expression levels of myostatin-1 in white 
64 
muscle and myostatin-2 in both white and red muscle from hormone treated fish were 
compared to those in controls to evaluate the effect of hormones on myostatin 
expression in silver sea bream. 
Silver sea bream used in this study is a kind of excellent food fish with high 
commercial value. It has extensive postlarval muscle growth and can reach large adult 
size (Rowlerson and Veggetti 2001 ). So it is an excellent model for studying muscle 
development of teleost fish (Maccatrozzo et al., 2001 b). 
4.3 Materials and methods 
4.3.1 Experimental fish 
Silver sea bream (Sparus sarba) weighing from 40 to 60 g were obtained from a 
local fish farm and kept in recirculating and aerated seawater [3 3 parts per thousand 
(ppt)] in the Simon FS Li Marine Science Laboratory, the Chinese University of Hong 
Kong. Fish were fed daily with a formulated diet (Woo and Kelly, 1995). All the 
hormone injection experiments were carried out in the summer when water 
temperatures reached 26-28 °C. 
4.3.2 Growth hormone injection 
Fish were randomly divided into three groups and maintained separately 1n 
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aerated seawater tanks for one month before growth hormone or saline injection. 
Three groups of fish received either daily intraperitoneal injection of saline (0.8% 
NaCl), 10ng/g BW recombinant bream growth hormone (rbGH) (Hospira, Lake 
Forest, IL, USA), or 1JJg/g BW rbGH for four days. Injections were given between 
10-11 am, and the last injection was administered 24h prior to sacrifice. Fish were fed 
daily with a formulated diet (Woo and Kelly, 1995). After the injection protocol was 
complete, fish were removed from water and killed by spinal transection. White and 
red muscle samples collected from fish were stored in TRI Reagent® (Molecular 
Research Center, Inc., Cincinnati, OH) in -80°C until extracted for total RNA. RT -
Realtime PCR were performed to evaluate the myostatin expression by using methods 
described in Chapter 3. 
4.3 .3 11-ketotestosterone and cortisol injection 
For 11-ketotestosterone injection experiment, fish were randomly divided into 
three groups and maintained separately in aerated seawater tanks for one month 
before 11-ketotestosterone or saline injection. Three groups of fish received either 
single intraperitoneal injection of DMSO, 50 ng/g BW 11-ketotestosterone (Cosmo 
Bio, Tokyo, Japan), or 2.5 J_lg/g BW 11-ketotestosterone. 
For cortisol injection experiment, fish were randomly divided into two groups 
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and maintained separately in aerated seawater tanks for one month before cortisol 
injection. Two groups of fish weighing from 40 to 60 g were received either single 
intraperitoneal injection of saline (0.8% NaCl), or 50 ~gig BW cortisol (Solu-Cortef, 
Pharmacia & Upjohn, Belgium). 
Injections were given between 1 0-11 am. Fish were fed daily with a formulated 
diet (Woo and Kelly, 1995). Fish were removed from water and killed by spinal 
transaction on the third day. Tissue samples including white muscle and red muscle 
collected from fish were stored in TRI Reagent® (Molecular Research Center, Inc., 
Cincinnati, OH) in -80°C until extracted for total RNA. RT - Realtime PCR were 
performed to evaluate the myostatin expression by using methods described in chapter 
3. 
4.3.4 Muscle tissue culture and hormone exposure 
According to Negatu's method (Negatu and Meier, 1995), both white and red 
muscle were collected and chopped into 1mm thick pieces using Mcilwain tissue 
chopper (Brinkmann, Westbury, NY). Each piece had a surface of nearly 4 by 5 mm 
for white muscle and 2 by 4 mm for red muscle. The muscle explants were washed 
with DMEM (Invitrogen, Carlsbad, CA) with 105 U/L penicillin, 105 U/L 
streptomycin and 6 g/L HEPES. Muscle explants were divided to four groups: control 
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DMEM, DMEM with 100 ng/ml sea bream growth hormone, DMEM with 100 ng/ml 
11-ketotestosterone and DMEM with 1000 ng/ml cortisol. These doses were chosen 
according to previous studies of our laboratory (Leung et al., 2008) and my 
preliminary results where significant metabolic effects of these hormones have been 
observed. The four groups of tissue slices were incubated at 28oC for 24 h before 
collection. Collected sample were stored in TRI Reagent® (Molecular Research 
Center, Inc., Cincinnati, OH) in -80°C until extracted for total RNA. RT - Realtime 
PCR were performed to evaluate to myostatin expression by using methods described 
in Chapter 3. 
4.3 .5 Primary pituitary cell culture and cortisol exposure 
To check the possible effect of cortisol on growth hormone secretion, primary 
pituitary cell culture was performed based on the protocol developed by Kwong et al 
(Kwong et al., 2009). Pituitaries of silver sea bream were removed and placed in 
Leibovitz's L15 medium. Pituitaries were washed and diced into 0.5 mm x 0.5mm 
fragments using a MciLWAIN tissue chopper (Brinkmann, Westbury, NY). Pituitary 
fragments were washed and then incubated with 0.25% trypsin (Sigma, StLouis, MO) 
at 28oC with gentle shaking for 45 minutes. After digestion, cells were incubated in 
L15 medium containing 10% fetal bovine serum (FBS) for 5 minutes and then in Ll5 
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medium containing DNase II (10 ~g/ml) for another 5 minutes. Mechanical dispersion 
was performed and then the cells were filtered by cell strainer ( 40 ~m, BD 
Biosciences, Bedford, MA). The dispersed pituitary cells were centrifuged at 300 x g 
for 10 minutes and resuspended in L15 medium and then plated in BD Falcon® 
24-well plate (Becton Dickinson, Franklin Lakes, NJ) at a density of 0.4 million cells 
per well. Total cell count was estimated using a hemocytometer. Cell viability was 
above 90% as checked by using trypan blue exclusion. The primary pituitary cells 
were allowed to recover overnight at 28oC in a humidified atmosphere. After 
overnight incubation, the pituitary cells were incubated in fresh L 15 medium for 30 
minutes first and then the medium was replaced by 1~M (about 360ng I ml) cortisol 
containing L 15 medium. After 2 hours of cortisol exposure, the medium was collected 
for measurement of growth hormone using enzyme-linked immunosorbent assay 
(ELISA). 
4.3.6 Measurement of growth hormone secretion by ELISA 
100 ~1 medium samples and standards were coated in Costar® 9018 EIA/RIA 
96-well plate (Coming, Coming, NY) at 4oC for overnight. After washing with PBS, 
the plate was incubated in blocking buffer containing 5% (w/v) skimmed-milk in 
PBS-T for 2 hours at 3 7°C. Then the wells were washed with PBS and incubated in 
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1:500 diluted anti-sea bream growth hormone antibody prepared previously by Deane 
and Woo (2006) in PBS-T for 1 hour at room temperature. After washing with PBS, 
anti-rabbit horseradish peroxidase-conjugated secondary antibody (Amersham) was 
added to each well at a dilution of 1: 1000 and incubated for 1 hour at room 
temperature. After the 1 hour incubation, the plate was washed with PBS and added 
with 3, 3 ', 5, 5' - tetramethylbenzidine (TMB) (Sigma) in 0.05M phosphate-citrate 
buffer with 0.03% sodium perborate (pH 5) (Sigma) as a substrate. After 10 minutes 
of incubation, 2M H2S04 was added to each well to stop color development and 
absorbance was read in a microplate spectrophotometer (SPECTRAmax ™250, 
Molecular Devices, Sunnyvale, CA) at wavelength of 450nm. 
4.3. 7 Data processing and statistical analysis 
The mRNA expression levels of myostatin-1 and myostatin-2 were normalized 
against 18s rRNA expression and expressed relative to the expression level of the 
control injection group, which was assigned a value of 100%. Data were presented as 
mean ± SEM. Statistical analyses were performed by statistical program 
SIGMASTAT 2.0 and the differences were considered to be significant at p-value < 
0.05 by one-way Analysis of Variance (ANOVA) and Newman-Keuls Multiple 
Comparison Test for more than two groups and by T-test for two groups. 
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4.4 Results 
4.4.1 Growth hormone injection 
In silver sea bream injected intraperitoneally with growth hormone at doses of 10 
ng/g BW and 1f.lg/g BW, myostatin-1 mRNA abundance in white muscle decreased 
dramatically by 83% and 88% respectively (Fig. 4.1 A). Different from white muscle, 
myostatin-1 expression in red muscle was increased significantly by 3.4-fold 
following injection of 10 ng/g BW growth hormone (Fig. 4.1 B). There was no 
significant change in red muscle myostatin-2 expression following growth hormone 
injection (Fig. 4.1 C). 
4.4.2 11-ketotestosterone injection 
In silver sea bream injected intraperitoneally with 11-ketotestosterone at doses of 
50 ng/g BW and 2.5 J.lg/g BW, myostatin-1 mRNA expression level was decreased 
significantly in red muscle at the dose 2.5f.lg/g BW (Fig. 4.2 B). There were no 
significant differences in white muscle myostatin-1 expression and in red muscle 
myostatin-2 expression (Fig. 4.2 A & C). 
4.4.3 Cortisol injection 
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In silver sea bream injected intraperitoneally with 50 f.lg/g BW cortisol, 
myostatin-1 mRNA expression level in white muscle decreased significantly by 70% 
(Fig. 4.3 A) while in the red muscle, both myostatin-1 and myostatin-2 expression 
were unchanged following cortisol treatment (Fig. 4.3 B &C). 
4.4.4 In vitro hormone treatment -growth hormone, 11-ketotestosterone and cortisol 
In red muscle explants culture exposed to growth hormone (1 00 ng/ml), 
myostatin-1 expression was stimulated 1.81-fold while for myostatin-2, it remained 
unchanged on exposure to growth hormone (Fig. 4.4 A & B). Both cortisol and 
11-ketotestosterone had no significant effect on myostatin-1 and myostatin-2 mRNA 
expression level in red muscle explants culture (Fig. 4.4 A & B). 
4.4.5 Pituitary cell growth hormone secretion under cortisol treatment 
Growth hormone secretion was measured 2 h after pituitary cell incubation with 
1 J.!M cortisol. Pituitary cell growth hormone secretion was stimulated by cortisol 































































(C) Control injection GH-L GH-H 
Fig. 4.1. Effect of intraperitoneal growth hormone injection on myostatin-1 (MSTN1) 
mRNA expression in white muscle (A), red muscle (B) and myostatin-2 (MSTN2) 
expression in red muscle (C). GH-L indicates (10 ng/g BW); GH-H indicates (1~g/g 
BW). Data are presented as means ± SEM (n = 5-7 for each group). Significant 
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Control injection 11KT-L 11KT-H (C) 
Fig. 4.2. Effect of intraperitoneal 11-ketotestosterone injection on myostatin-1 
(MSTN1) mRNA expression in white muscle (A), red muscle (B) and myostatin..:2 
(MSTN2) expression in red muscle (C). 11KT5 indicates 50 ng/g BW. 11KT250 
indicates 2.5 f.lg/g BW. Data are presented as means ± SEM (n = 5-7 for each group). 
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Control injection Cortisol (C) 
Fig. 4.3. Effect of intraperitoneal injection of cortisol (50 Jlglg BW) on myostatin-1 
(MSTNl) mRNA expression in white muscle (A), red muscle (B) and myostatin-2 
(MSTN2) expression in red muscle (C). Data are presented as means ± SEM (n = 5-6 
for each group). Significant difference (p < 0.05) between groups is illustrated in each 
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Control Cortisol 
Fig. 4.4. Effect of 24 h in vitro exposure to 1 OOng/ml growth hormone (GH), 
1 OOng/ml 11 ketotestosterone (11 KT) and 1 OOOng/ml cortisol on myostatin-1 
(MSTN1) (A) and myostatin-2 (MSTN2) (B) mRNA expression of red muscle explant 
culture. Data are presented as means ± SEM (n = 6 for each group). Significant 
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Control 1 ~ cortisol exposure 
Fig. 4.5. Growth hormone secretion from sea bream pituitary cell culture upon in vitro 
cortisol exposure for 2 h. Growth hormone secretion was measured by ELISA. Data 
are presented as means± SEM (n = 5 for each group). Significant difference (p < 0.05) 
between groups is illustrated in each figure by asterisk. 
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4.5 Discussion 
We have investigated the effects of growth hormone, 11-ketotestosterone and 
cortisol on the expression of myostatin transcripts in the muscle of silver sea bream. 
All these three hormones play important roles in muscle growth. Growth hormone and 
testosterone are suggested to be anabolic. Growth hormone can stimulate muscle mass 
directly or indirectly through IGF-1 (Aroniadou-Anderjaska et al., 1996; Gautsch et al., 
1999; Ullman and Oldfors, 1989). Testosterone also has anabolic effect on skeletal 
muscle growth (Giannoulis et al., 2008; Mauras, 2006). Cortisol is a catabolic stress 
hormone and exerts negative effect on growth (Sherwood et al., 2005). 
Growth hormone cell specific elements have been identified in the upstream of 
the transcriptional start site of both ov MSTN (MSTN1) and b/m MSTN (MSTN2) in 
brook trout and the element was also found in channel catfish (Roberts and Goetz, 
2003). In addition, growth hormone receptor (GHR) expression showed a higher level 
in double muscled bovine when compared to the normal animals (Listrat et al., 2005). · 
So these results suggest an interaction between growth hormone and myostatin. 
Although there were some studies which showed the lack of that relationship in 
human and porcine (Brill et al., 2002; Ji et al., 1998), other experiments carried out in 
hypopituitary growth hormone-deficient adults showed that growth hormone 
treatment significantly inhibited myostatin mRNA expression by 70%, and the 
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inhibitory effect was sustained during the period of growth hormone treatment (Liu et 
al., 2003). In the same study, the effect of growth hormone on myostatin was also 
tested in vitro in C2C 12 cell line to evaluate the potent direct effect of growth 
hormone on myostatin regulation. Myostatin expression level was decreased 24 hours 
after growth hormone incubation with doses ranging from 50 ng/ml to 1000 ng/ml 
(Liu et al., 2003). In addition, a dose of 25 ng/ml growth hormone already resulted in 
inhibition of myostatin at the protein level (Liu et al., 2003). 
There were also a few experiments studying growth hormone effect on myostatin 
expression in teleosts. In a study using transgenic salmon overexpressing growth 
hormone as model, growth hormone had no effect on myostatin-1, but resulted in a 
decrease in white muscle myostatin-2 expression and an increase in red muscle 
myostatin-2 expression. However, at protein level, mature myostatin protein was 
decreased in both red and white muscle (Roberts et al., 2004). Growth hormone 
injection In rainbow trout resulted In differential regulation of myostatin-1 and · 
myostatin-2: growth hormone induced myostatin-1 but reduced myostatin-2 (Biga et 
al., 2004). Growth hormone injection regulate myostatin levels differentially between 
two species in another study in which myostatin was down-regulated in GH-treated 
giant danio and up-regulated in GH-treated zebrafish (Biga et al., 2004). 
These results suggest the interaction of growth hormone and myostatin IS 
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complex. 
In the present study, in silver sea bream injected intraperitoneally with growth 
hormone, myostatin-1 mRNA abundance in white muscle decreased dramatically. 
This result is consistent with the expected in which growth hormone inhibits 
myostatin. However, different from white muscle, myostatin-1 expression in red 
muscle was increased significantly at the 10 ng/g BW dose by 3.4-fold. There was no 
significant change in red muscle myostatin-2 expression. The direct effect of growth 
hormone on myostatin in red muscle was also confirmed in red muscle explant culture 
in which a significant increase of myostatin-1 expression was found when expose red 
muscle to 1 OOng/ml growth hormone. Thus the responses of white muscle and red 
muscle to growth hormone were very different. Growth hormone receptor mRNA 
expression level was higher in fast white muscle than that in slow red muscle (Casse 
et al., 2003). In addition, our results showed that myostatin was differentially 
expressed in white muscle and red muscle of sea bream. There were some studies 
which showed that growth hormone could alter the ratio of white muscle to red 
muscle within the fish musculature, for example, growth hormone has been shown to 
induce white muscle proportion and inhibit red muscle proportion (Hennessey et al., 
2001; Lange et al., 2002). However, there were also some other studies which 
indicated that growth hormone had no effect on muscle fiber composition (Cuneo et 
83 
... 
al., 1992; Woodhouse et al., 1999). A possible explanation for the increased 
myostatin-1 mRNA expression in red muscle and the decreased myostatin-1 mRNA in 
white muscle is that growth hormone can regulate the ratio of white muscle to red 
muscle through the inhibitory action of myostatin on muscle growth. 
11 ketotestosterone (11 KT) is a kind of fish specific testosterone and testosterone 
is known to exert profound anabolic effects on animals. 11 KT is therefore expected to 
inhibit myostatin mRNA expression in fish muscle as testosterone has been shown to 
inhibit myostatin expression in mammalian muscle (Mendler et al., 2007). Our results 
are also consistent with the expectation that 11KT injection caused a decreased 
myostatin-1 mRNA level in red muscle. Although there is no significant difference 
for myostatin-1 in white muscle, myostatin-2 in red muscle and myostatin-1 in red 
muscle explant culture, a trend towards downregulation of myostatin by 11 KT 
treatment is evident. 
A glucocorticoid response element was identified on the myostatin promoter 
region (Ma et al., 2001 ), indicating the presence of an interaction between 
glucocorticoid and myostatin. However, results of different studies are in conflict. In 
rat, myostatin mRNA was increased after injection of dexamethasone (Dex) in several 
studies (Lang et al., 2001; Ma et al., 2003). In addition, myostatin gene deletion can 
prevent glucocorticoid-induced muscle atrophy (Gilson et al., 2007). However, some 
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studies on fish species showed an opposite result: in cortisol-immersed tilapia larvae, 
myostatin mRNA was reduced at 3h and 6h respectively (Rodgers et al., 2003). 
Mammalian and tilapia myostatin mRNA appear to be differentially regulated by 
these stress hormones (Rodgers et al., 2003). Results similar to those in tilapia were 
found in channel catfish in which a decrease in myostatin expression was recorded at 
12 hours post dexamethasone injection (Weber et al., 2005). Our results also showed a 
significant decrease in white muscle myostatin-1 following cortisol treatment, 
consistent with the studies carried out on tilapia and channel catfish. Furthermore, 
fasting and stress which can lead to an increase in cortisol also resulted in a decreased 
myostatin expression in fish (Rodgers et al., 2003; Vianello et al., 2003 ). At present, it 
is unknown whether glucocorticoid regulates the in vivo expression of myostatin in a 
direct or indirect fashion. Although dexamethasone injection led to decreased 
myostatin expression In channel catfish, it had no effect on the abundance of 
myostatin mRNA in channel catfish primary muscle cell culture (Weber et al., 2005). 
It IS possible that dexamethasone or cortisol injection indirectly regulates the 
expression of myostatin through the alteration of other factors such as growth 
hormone. Cortisol is suggested to stimulate growth hormone secretion In tilapia 
(Uchida et al., 2004). The result of the present study performed on silver sea bream 
pituitary cell culture also showed that cortisol enhanced growth hormone secretion. 
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Therefore, a possible mechanism for cortisol regulation on myostatin is that cortisol 
regulates myostatin expression through the action of growth hormone. 
This study has involved treating silver sea bream with growth hormone, 11-keto 
testosterone and cortisol. Growth hormone was shown to inhibit myostatin-1 in white 
muscle but induce it 1n red muscle. 11 KT decreased the expression level of 
myostatin-1 in red muscle. Cortisol treatment resulted in a decreased mRNA amount 
of myostatin-1 in white muscle. These results demonstrated that myostatin-1 has 
complex interactions with the hormones involved with growth regulation and further 
attest that hormones may regulate skeletal muscle growth through the action of 
myostatin. However, hormones have no effect on myostatin-2 expression, and that 
myostatin-2 may perform some unknown functions in silver sea bream. 
86 
Chapter 5 
A possible new function of myostatin-1 : Effect of 
extracellular osmolarity on myostatin in 




Myostatin is a member of the transforming growth factor (TGF) -beta 
family. Members from this family play critical multiple roles in cell proliferation and 
differentiation. In gilthead sea bream, zebrafish, salmon and our model fish silver sea 
bream as well, myostatin-1 was expressed in osmoregulation related organs gill and 
kidney (Ostbye et al., 2001; Radaelli et al., 2003). In gills, myostatin-1 was found in 
either chloride or mucus cell in Ostbye's study (Ostbye et al., 2001 ). Considering the 
function of myostatin in myoblasts proliferation and differentiation and the role of 
TGF -beta family member in cellular differentiation, myostatin may play a role in 
chloride cell differentiation. In kidney, exposure to different salinities led to rapid 
changes in renal morphometries in silver sea bream (Wong and Woo, 2006) and 
myostatin-1 may be involved in these changes. In the present study, two sets of 
experiments were carried out: the first experiment involved the long term adaptation 
of fish to 33ppt, 12ppt and 6ppt respectively and the second experiment involved 
abrupt transfer of fish from 33ppt to 6ppt. Expression levels of myostatin-1 in white 
muscle, red muscle, gill and kidney were recorded and compared among fish groups 
adapted to different salinity conditions. The expression of myostatin- 1 in all these 
tissues · was unchanged over the salinity range tested in long term adaptation 
· experiment and abrupt transfer experiment for 72h. However, there were significant 
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Increases of myostatin-1 expression In red muscle and gill and a decrease of 
myostatin-1 in kidney in silver sea bream 24h after abrupt transfer from 33ppt to 6ppt. 
These results showed that myostatin-1 may be involved in short term adaptation for 
salinity change. 
5.2 Introduction 
In fish species, there are two myostatin genes. The two myostatin genes were 
identified in many other teleosts such as gilthead sea bream, Atlantic salmon and 
white bass (Maccatrozzo et al., 2001a; Ostbye et al., 2001; Roberts and Goetz, 2001; 
Rodgers et al., 2001 ). The expression pattern of myostatin in fish species was very 
different from that in mammals. Myostatin-2 was mainly expressed in muscle and 
brain. However, myostatin-1 was expressed in many different tissues, suggesting that 
in fish, the function of myostatin-1 may not be confined to the skeletal muscle alone 
(Maccatrozzo et al., 2001a; Ostbye et al., 2001; Roberts and Goetz, 2001; Rodgers et 
al., 2001 ). 
Myotatin-1 was expressed in gill and kidney in many teleost species such as sea 
bream, zebrafish and salmon (Ostbye et al., 2001; Radaelli et al. , 2003). Gill and 
kidney are important organs responsible for osmoregulation in fish, suggesting that 
myostatin may play roles in the osmoregulatory processes. 
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In gills, myostatin-1 was found in either chloride or mucus cell at primary lamellae in 
Ostbye's study (Ostbye et al., 2001). Chloride cells were especially important in the 
process osmoregulation (Hwang and Lee, 2007). They are major site of ion secretion 
and absorption (Kaneko et al., 2002). The morphology of chloride cells in seawater 
adapted fish and fresh water adapted fish are different. Many studies showed that 
chloride cells can alternate their morphology and ion-transporting functions when 
exposed to abrupt environmental osmotic changes (Kaneko et al., 2002; Katoh and 
Kaneko, 2003). Considering the inhibitory function of myostatin in myoblasts 
proliferation and differentiation and the role of TGF -beta family members in cellular 
differentiation, it is possible that myostatin may play a role in chloride cell 
differentiation in fish gills. In mouse, GDF -11 which shares a very similar bioactive 
domain with myostatin, was found to be expressed in the mandibular and hyoid arches. 
These two bones represent the first and second visceral arches which are 
mesenchymal structures in the region of the embryonic pharynx. Gill arches of fish 
constitute the 3rd± 7th visceral arches (Ostbye et al., 2001 ). In view of the homology 
of the visceral arches between fish and mammals, and the similar localization of 
GDF -11 and myostatin in homologous organs, it is reasonable to postulate that 
myostatin-1 may have similar function with GDF -11 in the gill by affecting branchial 
cell differentiation. 
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Regarding the . kidney, previous work of our laboratory has shown that there are 
rapid changes in renal morphometries in silver sea bream on exposure to different 
salinities (Wong and Woo, 2006). Abrupt transfer of fish from 33ppt to 6ppt led to a 
dramatic rapid proliferation of collecting tubules after 24 hours. Myostatin which 
function in myoblast proliferation and differentiation may be involved in that process. 
In the present study, fish were exposed to different salinity conditions to 
investigate whether myostatin-1 plays a role in osmoregulation in silver sea bream. 
Two sets of experiments were carried out: the first experiment involved the long term 
adaptation of fish to 33ppt, 12ppt and -6ppt respectively and the second experiment 
involved abrupt transfer of fish from 33ppt to 6ppt. Expression levels of myostatin-1 
in white muscle, red muscle, gill and kidney were recorded and compared among fish 
groups adapted to different salinity conditions. Since both gill and kidney are blood 
rich organs, myostatin expression in whole blood has been tested first to eliminate the 
possible contamination by blood cell. 
Silver sea bream used in this study is an excellent model for studying 
osmoregulation. Silver sea bream is a kind of euryhaline fish which can tolerate a 
wide range of salinities (0-70ppt) (Wong et al., 2006). 
5.3 Materials and methods 
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5.3.1. Experimental fish 
Silver sea bream (Sparus sarba) were obtained from a local fish farm and kept in 
recirculating and aerated seawater [33 parts per thousand (ppt)] in the Simon FS Li 
Marine Science Laboratory, the Chinese University of Hong Kong. 
5.3.2 Long term salinity adaptation 
Fish were randomly divided into three groups and maintained separately in 
aerated seawater tanks for one and half month before adaptation to three different 
salinities (6ppt, 12ppt and 33ppt). The-low salinities (6ppt and 12ppt groups) were 
achieved by diluting seawater with dechlorinated tap water daily for two weeks until 
the final salinities were reached. Fish were fed daily with a formulated diet (Woo and 
Kelly, 1995) and cultured for one month before experiments. 
5.3.3 Abrupt transfer from seawater to brackish water (6 ppt) 
Hyposmotic brackish water (6ppt) was obtained by diluting seawater (33 ppt) 
with fully aerated tap water. Fish were then abruptly transferred from seawater 
holding tanks (33ppt) to experimental tanks containing brackish water at 6 ppt. Fish 
were sampled 24 and 72 hours after abrupt transfer. Control transfer groups were 
transferred from the original 33ppt seawater tank to another 33ppt seawater tank and 
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sampled at the same time intervals as the fish transferred to brackish water. 
5.3 .4 Data processing and statistical analysis 
The mRNA expression of myostatin-1 were normalized against 18s rRNA 
expression and expressed relative to control group which was assigned a value of 
1 OOo/o. For the specific control groups, see figure legends for details. Data were 
presented as mean ± SEM. Statistical analyses were performed us1ng statistical 
program SIGMASTAT 2.0 and the differences were considered to be significant at 
p-value < 0.05 by one-way Analysis -of Variance (ANOVA) and Newman-Keuls 
Multiple Comparison Test. 
5.4 Results 
5.4.1 Long term adaptation to different salinities 
By using real-time PCR, the expression of myostatin-1 was studied in white 
muscle, red muscle, gill and kidney of silver sea bream adapted to different salinities 
for one month. The expression of myostatin-1 in all these tissues was unchanged over 
the salinity range tested. (Fig. 5.1) 
5.4.2. Abrupt transfer from 33ppt to 6ppt- 24 h 
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Silver sea bream were transferred from 33ppt to 6ppt, myostatin-1 expression of 
white muscle, red muscle, gill and kidney was measured using real-time PCR after 24 
hours. Expression levels of a fish group that remained at 33ppt (no transfer) were also 
measured so as to evaluate effect of the transfer process per se as compared to the 
control transfer (33ppt-33ppt). There is no significant change in myostatin-1 
expression in all tissues in fish subjected to control transfer except that the kidney 
exhibited a decrea.se after control transfer (Fig. 5.2D). Myostatin-1 expression in both 
red muscle and gill increased significantly 24h after transfer by 1.97 and 2.65-fold 
respectively (Fig. 5 .2B & Fig. 5 .2C) ·while in the kidney, abrupt transfer showed 
significant decrease in myostatin-1 mRNA level by 80%. Expression of myostatin-1 
in white muscle and myostatin-2 in red muscle remained unchanged after abrupt 
transfer. 
5.4.3 Abrupt transfer from 33ppt to 6ppt- 72 h 
Silver sea bream were transferred from 33ppt to 6ppt, expression levels of 
myostatin-1 of white muscle, red muscle, gill and kidney were measured using 
real-time PCR after 72 hours. A group remained in 33ppt was set up to evaluate the 
effect of the transfer process per se. There was no significant change in myostatin-1 
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Figure 5.1 Myostatin-1 (MSTN 1) expression of white muscle (A), red muscle (B), gill 
(C) and kidney (D) in silver sea bream adapted to salinities of 6 parts per thousand 
(ppt; hypoosmotic), 12 ppt (isoosmotic), 33 ppt (seawater, hyperosmotic) for 4 weeks. 
Control group: 33ppt. Data are presented as means± SEM (n = 8-9 for each group). 
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Figure 5.2 Myostatin-1 (MSTNl) expression of white muscle (A), red muscle (B), gill 
(C) and kidney (D) in silver sea bream abruptly transferred to hypoosmotic salinity 
(6ppt) after 24h. Control group: fish remained in 33ppt. Data are presented as means± 
SEM (n = 5-6 for each group). Significant difference (p < 0.05) between groups is 
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Figure 5.3 Myostatin-1 (MSTNl) expression of white muscle (A), red muscle (B), gill 
(C) and kidney (D) in silver sea bream abruptly transferred to hypoosmotic salinity 
(6ppt) after 72h. Data are presented as means ± SEM (n = 5-6 for each group). 
Significant difference (p < 0.05) between groups is illustrated in each figure by 
different letters. 
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5. 5 Discussion 
We have investigated the changes in myostatin-1 expression level in seawater 
silver sea bream gill, kidney, as well as muscles after acclimation to brackish water ( 6 
ppt) and upon abrupt transfer from seawater to brackish water. Myostatin was 
expressed in gill and kidney in many teleost species such as sea bream, zebrafish and 
salmon (Ostbye et al., 2001; Radaelli et al., 2003). In the fish model used in present 
study, silver sea bream, myostatin was also expressed in these two organs. Gill and 
kidney are key organs responsible for osmoregulation in fish. 
Compare to silver sea bream adapted to seawater (33 ppt), there was no change 
in myostatin-1 mRNA expression in all tissues examined in fish adapted to both 12 
ppt and 6 ppt. These data showed that long term adaptation of silver sea bream to 
isoosmotic and hypoosmotic salinities had no effect on myostatin expression and so 
the myostatin-1 gene may be not involved in osmoregulation. 
Interestingly, in abrupt transfer experiments, myostatin-1 expression levels of red 
muscle and gill were increased significantly 24h after transfer to brackish water by 
2-fold and 2.6-fold respectively when compared to those of the control transfer 
(33ppt-33ppt). However, for kidney, there was a significant decrease of myostatin-1 
mRNA abundance 24h after abrupt transfer. For 72h after abrupt transfer from sea 
water to brackish water, there were no changes in myostatin-1 expression in all 
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tissues. 
Changes in myostatin expression 24 hours after abrupt transfer in gill and kidney 
but no expression difference was observed after long term adaptation or 72 hours after 
abrupt transfer indicate that myostatin may be involved in the short term response of 
seawater to fresh water transfer. 
Because of the very basic and experimental nature of our studies, and the lack of 
information on the role of myostatin in gill and kidney, it is difficult to draw any 
conclusions on any possible role for myostatin in fish osmoregulation. We can only 
suggest that myostatin may play a role in chloride cell differentiation in fish gills by 
considering the function of myostatin in myoblast, the role of TGF -beta family 
members in the cells and the likely occurrence of myostatin in gill chloride cell 
(Ostbye et al., 2001 ). 
The morphology of chloride cells In seawater adapted fish and fresh water 
adapted fish are markedly different. Seawater-type chloride cells have a pit structure 
on the apical surface, whereas freshwater-type cells have microvilli on the flat or 
projecting apical membrane (Katoh and Kaneko, 2003; Kelly and Woo, 1999a, b; 
Wong et al., 2006) Many studies showed that chloride cells can alternate their 
morphology and ion-transporting functions when exposed to abrupt environmental 
osmotic changes (Hiroi et al., 1999; Kaneko et al., 2002; Sakamoto et al., 2000). In a 
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study carried out on killifish, seawater-type chloride cells were transformed into 
freshwater-type cells 12h after abrupt transfer to freshwater. During the 
transformation, an intermediate type with characteristics of both seawater and 
freshwater chloride cells was found and was most frequently observed at 3h after 
abrupt transfer (Katoh and Kaneko, 2003). For 3 days (72h) after freshwater transfer 
in the same study, 14.7% of seawater-type cells were replaced with newly 
differentiated freshwater-type chloride cells. This percentage is considerably higher 
than that in seawater maintained group (1.2%). These data showed that there were two 
mechanisms for chloride cell adaptive response. The first is the short term response of 
morphological and functional transformation of pre-existing chloride cells; the second 
is long-term adaptive response in which the part of pre-existing chloride cell 
degenerated and replaced by newly differentiated cells (Katoh and Kaneko, 2003). 
Our results of gill myostatin-1 expression at 24h and 72h after abrupt transfer may be 
related to these transformation, degeneration and differentiation of chloride cells. 
For kidney, a significant decrease in myostatin-1 expression was observed 24h 
after abrupt transfer to 6 ppt. The previous work of our laboratory has shown that 
there are rapid changes in renal morphometries in silver sea bream on exposure to 
different salinities (Wong and Woo, 2006). Abrupt transfer from 33ppt to 6ppt induced 
rapid changes in morphology of renal tubules. The abrupt transfer led to a dramatic 
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rapid proliferation . of collecting tubules. Myostatin which function in myoblast 
proliferation and differentiation may be involved in that process but the mechanisms 
involved are yet unknown at this stage. 
Lastly, it is worth mentioning that abrupt salinity transfer is known to cause 
stress to fish, and therefore there remains a possibility that the responses of myostatin 
expression to abrupt transfer as observed in the present study may actually be due to 
the induced stress, and such a possibility cannot be ignored. 
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Chapter 6 
General Discussion and Conclusions 
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Myostatin is a negative regulator for muscle growth in mammals. One of the 
most important applications of studying myostatin is to find possible avenues for 
enhancing muscle growth. It is known that administration of myostatin antibody to 
animals generally does not result in changes in organ size and histology, or various 
serum parameters, suggesting that inhibition of myostatin in adults specifically 
increases skeletal muscle mass without side effect (Whittemore et al., 2003). In view 
of this, manipulation of endogenous myostatin levels may be feasible as one avenue 
for modulating muscle mass (muscle growth) which will find extreme usefulness in 
both agriculture and aquaculture. Manipulation of endogenous myostatin expression 
may have a greater commercial impact on fish culture than that of mammals as fish 
possess a larger ratio of muscle to non-muscle organs. So the study of myostatin in 
fish species is very important. 
The present study has investigated the influence of growth-related hormones and 
salinity regimes on the regulation of myostatin expression in the silver sea bream. In 
the first part of this study, the characteristics of the expression profiles of both 
myostatin-1 and myostatin-2 in silver sea bream were examined. The mRNA 
expressions of these two myostatins In silver sea bream In different seasons and 
different organs were also quantified. Both myostatin-1 and myostatin-2 were found to 
be expressed at lower levels in winter than that in summer. These finding suggested 
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that myostatin may be involved in the regulation of seasonal pattern for fish growth. 
In addition, the expression levels of both myostatin-1 and myostatin-2 were lower in 
white muscle than that in red muscle. These basic studies provide us with more 
knowledge about the expression pattern of the two forms of myostatins in silver sea 
bream. 
In the second part of study, the effects of growth hormone, 11-ketotestosterone 
and cortisol on myostatin mRNA expression in silver sea bream were studied. 
Injection of growth hormone and 11-ketotestosterone resulted In a decreased 
myostatin-1 expression In white muscle and red muscle, respectively. Growth 
hormone and 11-ketotestosterone are well documented to be growth enhancing 
hormones. The present results suggest that the growth-promoting effect of growth 
hormone and 11-ketotestosterone may partially act via suppressing myostatin 
expression in muscle, and that myostatin in fish, may act in a similar way described 
for mammals by acting as a negative regulator of muscle growth. Different from that 
in white muscle, growth hormone injection induced myostatin-1 expression in red 
muscle, suggesting the existence of a unique regulatory mechanism of myostatin 
expression in red muscle. The distinctly different response to growth hormone 
treatment of myostatin in white muscle and red muscle suggest that myostatin may 
play a role in regulation of the ratio of white muscle to red muscle. Regarding the 
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effect of cortisol, . some studies have shown a stimulatory effect of cortisol on 
myostatin expression (Lang et al., 2001; Ma et al., 2003), a finding which 
corroborates the generally observed negative effect of cortisol on muscle mass. 
However, In the present study, cortisol injection decreased the expression of 
myostatin-1 in white muscle. Studies on sea bream pituitary cell culture have shown 
that cortisol induced growth hormone secretion significantly in vitro. While other 
regulatory modes are possible, the reduction of myostatin expression by cortisol in the 
sea bream may likely to be mediated, at least partially, by a cortisol-stimulated growth 
hormone secretion. The three hormones we examined in the present study have 
different effects on myostatin gene expression. These three hormones are important 
growth related hormones. These results provide further evidence for the function of 
myostatin in growth regulation in fish. 
Lastly, the expression levels of myostatin-1 were analyzed in silver sea bream 
exposed to different salinity conditions. The more diverse myostatin expression 
pattern in fish suggests that the function of myostatin may not be only restricted to the 
fish musculature. As a member of TGF -beta family, it may also function in cellular 
proliferation and differentiation in other organs. Our experiments involving exposure 
of fish to different salinities were designed to test the role of myostatin in gill and 
kidney indirectly. Although the difference in environmental salinities resulted in 
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marked changes in .Physiological parameters, most of these changes are closely related 
to osmoregulatory function. Long-term adaptation to different salinities and abrupt 
transfer into hyposmotic salinity for 72h had no effect on myostatin-1 express1on. 
However, 1n samples collected 24h after abrupt transfer from 33ppt to 6ppt, 
myostatin-1 expression increased significantly in red muscle and gill but decreased 
dramatically in kidney. These findings reflected that myostatin-1 can be involved with 
short term salinity changes only. These results have been reported for the first time, 
and without further data, it is difficult to draw any conclusions on any possible role 
for myostatin in fish osmoregulation . . We can only suggest that myostatin may be 
somehow involved in osmoregulatory processes especially during short-term salinity 
adaptation in silver sea bream. 
The present study has performed a basic research on several factors regulating 
myostatin expression in both red and white muscles and some non-muscle organs in 
silver sea bream. These findings enable us to know more about the function of 










































Fig. 6.1: Summary of the main findings regarding the effects of hormones and salinity 
conditions on the expression pattern of myostatin-1 and myostatin-2 in different 
tissues and organs of silver sea bream (Sparus sarba) . 
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